<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<html>
 <body>
  <pubmedarticleset>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="MEDLINE">
     <pmid version="1">
      29511076
     </pmid>
     <datecompleted>
      <year>
       2019
      </year>
      <month>
       01
      </month>
      <day>
       22
      </day>
     </datecompleted>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       04
      </day>
     </daterevised>
     <article pubmodel="Electronic">
      <journal>
       <issn issntype="Electronic">
        2150-7511
       </issn>
       <journalissue citedmedium="Internet">
        <volume>
         9
        </volume>
        <issue>
         2
        </issue>
        <pubdate>
         <year>
          2018
         </year>
         <month>
          03
         </month>
         <day>
          06
         </day>
        </pubdate>
       </journalissue>
       <title>
        mBio
       </title>
       <isoabbreviation>
        mBio
       </isoabbreviation>
      </journal>
      <articletitle>
       Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.
      </articletitle>
      <elocationid eidtype="pii" validyn="Y">
       e00221-18
      </elocationid>
      <elocationid eidtype="doi" validyn="Y">
       10.1128/mBio.00221-18
      </elocationid>
      <abstract>
       <abstracttext>
        Emerging coronaviruses (CoVs) cause severe disease in humans, but no approved therapeutics are available. The CoV nsp14 exoribonuclease (ExoN) has complicated development of antiviral nucleosides due to its proofreading activity. We recently reported that the nucleoside analogue GS-5734 (remdesivir) potently inhibits human and zoonotic CoVs
        <i>
         in vitro
        </i>
        and in a severe acute respiratory syndrome coronavirus (SARS-CoV) mouse model. However, studies with GS-5734 have not reported resistance associated with GS-5734, nor do we understand the action of GS-5734 in wild-type (WT) proofreading CoVs. Here, we show that GS-5734 inhibits murine hepatitis virus (MHV) with similar 50% effective concentration values (EC
        <sub>
         50
        </sub>
        ) as SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV). Passage of WT MHV in the presence of the GS-5734 parent nucleoside selected two mutations in the nsp12 polymerase at residues conserved across all CoVs that conferred up to 5.6-fold resistance to GS-5734, as determined by EC
        <sub>
         50
        </sub>
        The resistant viruses were unable to compete with WT in direct coinfection passage in the absence of GS-5734. Introduction of the MHV resistance mutations into SARS-CoV resulted in the same
        <i>
         in vitro
        </i>
        resistance phenotype and attenuated SARS-CoV pathogenesis in a mouse model. Finally, we demonstrate that an MHV mutant lacking ExoN proofreading was significantly more sensitive to GS-5734. Combined, the results indicate that GS-5734 interferes with the nsp12 polymerase even in the setting of intact ExoN proofreading activity and that resistance can be overcome with increased, nontoxic concentrations of GS-5734, further supporting the development of GS-5734 as a broad-spectrum therapeutic to protect against contemporary and emerging CoVs.
        <b>
         IMPORTANCE
        </b>
        Coronaviruses (CoVs) cause severe human infections, but there are no approved antivirals to treat these infections. Development of nucleoside-based therapeutics for CoV infections has been hampered by the presence of a proofreading exoribonuclease. Here, we expand the known efficacy of the nucleotide prodrug remdesivir (GS-5734) to include a group β-2a CoV. Further, GS-5734 potently inhibits CoVs with intact proofreading. Following selection with the GS-5734 parent nucleoside, 2 amino acid substitutions in the nsp12 polymerase at residues that are identical across CoVs provide low-level resistance to GS-5734. The resistance mutations decrease viral fitness of MHV
        <i>
         in vitro
        </i>
        and attenuate pathogenesis in a SARS-CoV animal model of infection. Together, these studies define the target of GS-5734 activity and demonstrate that resistance is difficult to select, only partial, and impairs fitness and virulence of MHV and SARS-CoV, supporting further development of GS-5734 as a potential effective pan-CoV antiviral.
       </abstracttext>
       <copyrightinformation>
        Copyright © 2018 Agostini et al.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author equalcontrib="Y" validyn="Y">
        <lastname>
         Agostini
        </lastname>
        <forename>
         Maria L
        </forename>
        <initials>
         ML
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author equalcontrib="Y" validyn="Y">
        <lastname>
         Andres
        </lastname>
        <forename>
         Erica L
        </forename>
        <initials>
         EL
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Sims
        </lastname>
        <forename>
         Amy C
        </forename>
        <initials>
         AC
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Graham
        </lastname>
        <forename>
         Rachel L
        </forename>
        <initials>
         RL
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Sheahan
        </lastname>
        <forename>
         Timothy P
        </forename>
        <initials>
         TP
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Lu
        </lastname>
        <forename>
         Xiaotao
        </forename>
        <initials>
         X
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Smith
        </lastname>
        <forename>
         Everett Clinton
        </forename>
        <initials>
         EC
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Department of Biology, the University of the South, Sewanee, Tennessee, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Case
        </lastname>
        <forename>
         James Brett
        </forename>
        <initials>
         JB
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Feng
        </lastname>
        <forename>
         Joy Y
        </forename>
        <initials>
         JY
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Inc., Foster City, California, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Jordan
        </lastname>
        <forename>
         Robert
        </forename>
        <initials>
         R
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Inc., Foster City, California, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Ray
        </lastname>
        <forename>
         Adrian S
        </forename>
        <initials>
         AS
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Inc., Foster City, California, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Cihlar
        </lastname>
        <forename>
         Tomas
        </forename>
        <initials>
         T
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Inc., Foster City, California, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Siegel
        </lastname>
        <forename>
         Dustin
        </forename>
        <initials>
         D
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Inc., Foster City, California, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Mackman
        </lastname>
        <forename>
         Richard L
        </forename>
        <initials>
         RL
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Inc., Foster City, California, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Clarke
        </lastname>
        <forename>
         Michael O
        </forename>
        <initials>
         MO
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Inc., Foster City, California, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Baric
        </lastname>
        <forename>
         Ralph S
        </forename>
        <initials>
         RS
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA rbaric@email.unc.edu mark.denison@vanderbilt.edu.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Denison
        </lastname>
        <forename>
         Mark R
        </forename>
        <initials>
         MR
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA rbaric@email.unc.edu mark.denison@vanderbilt.edu.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <grantlist completeyn="Y">
       <grant>
        <grantid>
         R01 AI108197
        </grantid>
        <acronym>
         AI
        </acronym>
        <agency>
         NIAID NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
       <grant>
        <grantid>
         T32 AI112541
        </grantid>
        <acronym>
         AI
        </acronym>
        <agency>
         NIAID NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
       <grant>
        <grantid>
         T32 AI089554
        </grantid>
        <acronym>
         AI
        </acronym>
        <agency>
         NIAID NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
       <grant>
        <grantid>
         R01 AI132178
        </grantid>
        <acronym>
         AI
        </acronym>
        <agency>
         NIAID NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
       <grant>
        <grantid>
         P30 DK065988
        </grantid>
        <acronym>
         DK
        </acronym>
        <agency>
         NIDDK NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
       <grant>
        <grantid>
         U19 AI109680
        </grantid>
        <acronym>
         AI
        </acronym>
        <agency>
         NIAID NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
      </grantlist>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
       <publicationtype ui="D052061">
        Research Support, N.I.H., Extramural
       </publicationtype>
       <publicationtype ui="D013485">
        Research Support, Non-U.S. Gov't
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2018
       </year>
       <month>
        03
       </month>
       <day>
        06
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       United States
      </country>
      <medlineta>
       mBio
      </medlineta>
      <nlmuniqueid>
       101519231
      </nlmuniqueid>
     </medlinejournalinfo>
     <chemicallist>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D000998">
        Antiviral Agents
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D012265">
        Ribonucleotides
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        3QKI37EEHE
       </registrynumber>
       <nameofsubstance ui="C000606551">
        remdesivir
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        EC 3.1.-
       </registrynumber>
       <nameofsubstance ui="D005095">
        Exoribonucleases
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        OF5P57N2ZX
       </registrynumber>
       <nameofsubstance ui="D000409">
        Alanine
       </nameofsubstance>
      </chemical>
     </chemicallist>
     <citationsubset>
      IM
     </citationsubset>
     <meshheadinglist>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000409">
        Alanine
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000031">
        analogs &amp; derivatives
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000494">
        pharmacology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000818">
        Animals
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000998">
        Antiviral Agents
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000494">
        pharmacology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D017934">
        Coronavirus
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000187">
        drug effects
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000201">
        enzymology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D005095">
        Exoribonucleases
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000737">
        chemistry
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000235">
        genetics
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000378">
        metabolism
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D051379">
        Mice
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D009154">
        Mutation
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000235">
        genetics
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D012265">
        Ribonucleotides
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000494">
        pharmacology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D045473">
        SARS Virus
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000187">
        drug effects
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000235">
        genetics
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D014779">
        Virus Replication
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000187">
        drug effects
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000235">
        genetics
       </qualifiername>
      </meshheading>
     </meshheadinglist>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="Y">
       RNA polymerases
      </keyword>
      <keyword majortopicyn="Y">
       SARS-CoV
      </keyword>
      <keyword majortopicyn="Y">
       antiviral agents
      </keyword>
      <keyword majortopicyn="Y">
       antiviral resistance
      </keyword>
      <keyword majortopicyn="Y">
       coronavirus
      </keyword>
      <keyword majortopicyn="Y">
       nucleoside analogs
      </keyword>
      <keyword majortopicyn="Y">
       pandemic
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2018
       </year>
       <month>
        3
       </month>
       <day>
        8
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2018
       </year>
       <month>
        3
       </month>
       <day>
        8
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2019
       </year>
       <month>
        1
       </month>
       <day>
        23
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      epublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       29511076
      </articleid>
      <articleid idtype="pii">
       mBio.00221-18
      </articleid>
      <articleid idtype="doi">
       10.1128/mBio.00221-18
      </articleid>
      <articleid idtype="pmc">
       PMC5844999
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        PLoS Pathog. 2010 May 06;6(5):e1000896
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         20463816
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3048-53
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26976607
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Methods Mol Biol. 2015;1282:1-23
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25720466
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        N Engl J Med. 2012 Nov 8;367 (19):1814-20
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23075143
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nucleic Acids Res. 1997 Nov 15;25(22):4532-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         9358162
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nucleic Acids Res. 2003 Dec 15;31(24):7117-30
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14654687
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nat Med. 2000 Dec;6(12):1375-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         11100123
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Sci Transl Med. 2017 Jun 28;9(396):null
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28659436
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):E3900-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25197083
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12995-3000
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14569023
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Virol. 2009 Feb;83(4):2038-43
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19019971
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Virol. 2007 Nov;81(22):12135-44
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17804504
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5108-13
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16549795
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Antiviral Res. 2014 Jan;101:122-30
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24269475
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Antimicrob Agents Chemother. 2008 Feb;52(2):458-64
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17999967
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        N Engl J Med. 2017 Feb 9;376(6):584-594
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28177862
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        PLoS Pathog. 2013 Aug;9(8):e1003565
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23966862
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        PLoS Pathog. 2005 Oct;1(2):e11
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16220146
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        MBio. 2013 Aug 06;4(4):null
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23919993
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7289-94
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12754380
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nature. 2014 Apr 17;508(7496):402-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24590073
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Virol. 2016 Jul 27;90(16):7415-28
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27279608
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nat Rev Drug Discov. 2016 May;15(5):327-47
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26868298
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16038-43
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21896755
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Clin Microbiol Rev. 2007 Oct;20(4):660-94
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17934078
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Virol. 2005 Dec;79(24):15511-24
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16306622
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Antivir Chem Chemother. 2006;17(5):285-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17176633
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Methods Mol Med. 2005;107:183-206
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15492373
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        PLoS Med. 2006 Sep;3(9):e343
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16968120
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16157-62
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24043791
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Viruses. 2015 Sep 29;7(10):5206-24
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26426038
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Antimicrob Agents Chemother. 2006 Jun;50(6):2000-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16723558
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Clin Microbiol Rev. 2016 Jul;29(3):695-747
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27281742
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Virol. 2013 Apr;87(7):3741-51
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23325689
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        AIDS. 1998 May 7;12(7):705-12
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         9619801
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Biol Chem. 1981 Nov 25;256(22):11447-51
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         6271750
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Clin Microbiol Rev. 2015 Apr;28(2):465-522
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25810418
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Infect Dis. 2016 Apr 15;213(8):1240-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26603202
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nat Med. 2015 Dec;21(12):1508-13
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26552008
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Antiviral Res. 2013 Nov;100(2):407-19
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23994190
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Bioorg Med Chem Lett. 2012 Apr 15;22(8):2705-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         22446091
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Virol. 2013 Apr;87(7):3885-902
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23365422
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Virol. 2002 Nov;76(21):11065-78
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12368349
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Gastroenterol Hepatol (N Y). 2007 Mar;3(3):218-25
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21960835
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        MBio. 2014 Mar 25;5(2):e00047-14
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24667706
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Infect Public Health. 2016 May-Jun;9(3):220-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27095300
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2014 Aug 26;111(34):12516-21
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25114257
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Antimicrob Agents Chemother. 2013 Nov;57(11):5202-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23917318
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        N Engl J Med. 2003 May 15;348(20):1953-66
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12690092
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nat Protoc. 2011 Jun;6(6):925-33
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21637207
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Respirology. 2003 Nov;8 Suppl:S9-14
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15018127
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Sci Rep. 2017 Mar 06;7:43395
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28262699
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):E162-E171
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29279395
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Science. 1996 Mar 1;271(5253):1282-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         8638110
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2007 May 29;104(22):9463-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17517631
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 1973 Apr;70(4):1174-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         4197928
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nature. 2016 Mar 17;531(7594):381-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26934220
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Biol Chem. 2003 Dec 5;278(49):49164-70
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12966103
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32247927
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       14
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1873-0442
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          02
         </day>
        </pubdate>
       </journalissue>
       <title>
        Travel medicine and infectious disease
       </title>
       <isoabbreviation>
        Travel Med Infect Dis
       </isoabbreviation>
      </journal>
      <articletitle>
       Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence.
      </articletitle>
      <pagination>
       <medlinepgn>
        101647
       </medlinepgn>
      </pagination>
      <elocationid eidtype="pii" validyn="Y">
       S1477-8939(20)30116-2
      </elocationid>
      <elocationid eidtype="doi" validyn="Y">
       10.1016/j.tmaid.2020.101647
      </elocationid>
      <abstract>
       <abstracttext>
        The novel coronavirus infection that initially found at the end of 2019 has attracted great attention. So far, the number of infectious cases has increased globally to more than 100 thousand and the outbreak has been defined as a pandemic situation, but there are still no "specific drug" available. Relevant reports have pointed out the novel coronavirus has 80% homology with SARS. In the difficulty where new synthesized drug cannot be applied immediately to patients, "conventional drug in new use" becomes a feasible solution. The first medication experience of the recovered patients in the US has led remdesivir to be the "specific drug". China has also taken immediate action to put remdesivir into clinical trials with the purpose of applying it into clinical therapeutics for Corona Virus Disease 2019 (COVID-19). We started from the structure, immunogenicity, and pathogenesis of coronavirus infections of the novel coronavirus. Further, we analyzed the pharmacological actions and previous trials of remdesivir to identify the feasibility of conducting experiments on COVID-19.
       </abstracttext>
       <copyrightinformation>
        Copyright © 2020 Elsevier Ltd. All rights reserved.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Cao
        </lastname>
        <forename>
         Yu-Chen
        </forename>
        <initials>
         YC
        </initials>
        <affiliationinfo>
         <affiliation>
          The Second Clinical School, Southern Medical University, Guangzhou, 510515, Guangdong, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Deng
        </lastname>
        <forename>
         Qi-Xin
        </forename>
        <initials>
         QX
        </initials>
        <affiliationinfo>
         <affiliation>
          The Second Clinical School, Southern Medical University, Guangzhou, 510515, Guangdong, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Dai
        </lastname>
        <forename>
         Shi-Xue
        </forename>
        <initials>
         SX
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Gastroenterology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, South China University of Technology, Guangzhou, 510080, Guangdong, China. Electronic address: shixuedai@hotmail.com.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
       <publicationtype ui="D016454">
        Review
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        02
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       Netherlands
      </country>
      <medlineta>
       Travel Med Infect Dis
      </medlineta>
      <nlmuniqueid>
       101230758
      </nlmuniqueid>
      <issnlinking>
       1477-8939
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       Corona virus disease 2019
      </keyword>
      <keyword majortopicyn="N">
       Phase III clinical trial
      </keyword>
      <keyword majortopicyn="N">
       Remdesivir
      </keyword>
      <keyword majortopicyn="N">
       Severe acute respiratory syndrome coronavirus 2
      </keyword>
     </keywordlist>
     <coistatement>
      Declaration of competing interest The authors report no conflicts.
     </coistatement>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        05
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="revised">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        17
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        26
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        6
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        6
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        6
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32247927
      </articleid>
      <articleid idtype="pii">
       S1477-8939(20)30116-2
      </articleid>
      <articleid idtype="doi">
       10.1016/j.tmaid.2020.101647
      </articleid>
      <articleid idtype="pmc">
       PMC7151266
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2020 Feb 20;382(8):727-733
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31978945
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Cell Res. 2020 Mar;30(3):269-271
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32020029
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Cytokine. 2018 Apr;104:8-13
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29414327
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nat Rev Microbiol. 2009 Mar;7(3):226-36
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19198616
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2020 Mar 7;395(10226):764-766
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32105609
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6771-6776
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32054787
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2019 Dec 12;381(24):2293-2303
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31774950
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2020 Mar 19;382(12):1177-1179
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32074444
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Clin Exp Immunol. 2004 Apr;136(1):95-103
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15030519
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Feline Med Surg. 2019 Apr;21(4):271-281
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30755068
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nature. 2020 Mar;579(7798):270-273
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32015507
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nature. 2016 Mar 17;531(7594):381-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26934220
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Chembiochem. 2020 Mar 2;21(5):730-738
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32022370
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nat Commun. 2020 Jan 10;11(1):222
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31924756
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Med Virol. 2020 Apr;92(4):418-423
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31967327
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Bioorg Med Chem Lett. 2012 Apr 15;22(8):2705-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         22446091
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Sci China Life Sci. 2020 Mar;63(3):457-460
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32009228
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="MEDLINE">
     <pmid version="1">
      32020029
     </pmid>
     <datecompleted>
      <year>
       2020
      </year>
      <month>
       03
      </month>
      <day>
       23
      </day>
     </datecompleted>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       15
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1748-7838
       </issn>
       <journalissue citedmedium="Internet">
        <volume>
         30
        </volume>
        <issue>
         3
        </issue>
        <pubdate>
         <year>
          2020
         </year>
         <month>
          03
         </month>
        </pubdate>
       </journalissue>
       <title>
        Cell research
       </title>
       <isoabbreviation>
        Cell Res.
       </isoabbreviation>
      </journal>
      <articletitle>
       Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
      </articletitle>
      <pagination>
       <medlinepgn>
        269-271
       </medlinepgn>
      </pagination>
      <elocationid eidtype="doi" validyn="Y">
       10.1038/s41422-020-0282-0
      </elocationid>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Wang
        </lastname>
        <forename>
         Manli
        </forename>
        <initials>
         M
        </initials>
        <affiliationinfo>
         <affiliation>
          State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, 430071, Wuhan, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Cao
        </lastname>
        <forename>
         Ruiyuan
        </forename>
        <initials>
         R
        </initials>
        <affiliationinfo>
         <affiliation>
          National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, 100850, Beijing, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Zhang
        </lastname>
        <forename>
         Leike
        </forename>
        <initials>
         L
        </initials>
        <affiliationinfo>
         <affiliation>
          State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, 430071, Wuhan, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Yang
        </lastname>
        <forename>
         Xinglou
        </forename>
        <initials>
         X
        </initials>
        <affiliationinfo>
         <affiliation>
          State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, 430071, Wuhan, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Liu
        </lastname>
        <forename>
         Jia
        </forename>
        <initials>
         J
        </initials>
        <affiliationinfo>
         <affiliation>
          State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, 430071, Wuhan, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Xu
        </lastname>
        <forename>
         Mingyue
        </forename>
        <initials>
         M
        </initials>
        <affiliationinfo>
         <affiliation>
          State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, 430071, Wuhan, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Shi
        </lastname>
        <forename>
         Zhengli
        </forename>
        <initials>
         Z
        </initials>
        <affiliationinfo>
         <affiliation>
          State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, 430071, Wuhan, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Hu
        </lastname>
        <forename>
         Zhihong
        </forename>
        <initials>
         Z
        </initials>
        <identifier source="ORCID">
         0000-0002-1560-0928
        </identifier>
        <affiliationinfo>
         <affiliation>
          State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, 430071, Wuhan, China. huzh@wh.iov.cn.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Zhong
        </lastname>
        <forename>
         Wu
        </forename>
        <initials>
         W
        </initials>
        <affiliationinfo>
         <affiliation>
          National Engineering Research Center for the Emergency Drug, Beijing Institute of Pharmacology and Toxicology, 100850, Beijing, China. zhongwu@bmi.ac.cn.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Xiao
        </lastname>
        <forename>
         Gengfu
        </forename>
        <initials>
         G
        </initials>
        <affiliationinfo>
         <affiliation>
          State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, 430071, Wuhan, China. xiaogf@wh.iov.cn.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <grantlist completeyn="Y">
       <grant>
        <grantid>
         31621061
        </grantid>
        <agency>
         National Natural Science Foundation of China (National Science Foundation of China)
        </agency>
        <country>
         International
        </country>
       </grant>
      </grantlist>
      <publicationtypelist>
       <publicationtype ui="D016422">
        Letter
       </publicationtype>
       <publicationtype ui="D013485">
        Research Support, Non-U.S. Gov't
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        02
       </month>
       <day>
        04
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       England
      </country>
      <medlineta>
       Cell Res
      </medlineta>
      <nlmuniqueid>
       9425763
      </nlmuniqueid>
      <issnlinking>
       1001-0602
      </issnlinking>
     </medlinejournalinfo>
     <chemicallist>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D000962">
        Antimalarials
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D000998">
        Antiviral Agents
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        3QKI37EEHE
       </registrynumber>
       <nameofsubstance ui="C000606551">
        remdesivir
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        415SHH325A
       </registrynumber>
       <nameofsubstance ui="D000249">
        Adenosine Monophosphate
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        886U3H6UFF
       </registrynumber>
       <nameofsubstance ui="D002738">
        Chloroquine
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        M03GIQ7Z6P
       </registrynumber>
       <nameofsubstance ui="D012844">
        Sincalide
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        OF5P57N2ZX
       </registrynumber>
       <nameofsubstance ui="D000409">
        Alanine
       </nameofsubstance>
      </chemical>
     </chemicallist>
     <supplmeshlist>
      <supplmeshname type="Disease" ui="C000657245">
       COVID-19
      </supplmeshname>
      <supplmeshname type="Protocol" ui="C000705127">
       COVID-19 drug treatment
      </supplmeshname>
      <supplmeshname type="Organism" ui="C000656484">
       severe acute respiratory syndrome coronavirus 2
      </supplmeshname>
     </supplmeshlist>
     <citationsubset>
      IM
     </citationsubset>
     <meshheadinglist>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000249">
        Adenosine Monophosphate
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000031">
        analogs &amp; derivatives
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000494">
        pharmacology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000409">
        Alanine
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000031">
        analogs &amp; derivatives
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000494">
        pharmacology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000818">
        Animals
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="Y" ui="D000962">
        Antimalarials
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000494">
        pharmacology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="Y" ui="D000998">
        Antiviral Agents
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000494">
        pharmacology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000073640">
        Betacoronavirus
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000187">
        drug effects
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000472">
        pathogenicity
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D001681">
        Biological Assay
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D002522">
        Chlorocebus aethiops
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="Y" ui="D002738">
        Chloroquine
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000494">
        pharmacology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D018352">
        Coronavirus Infections
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000188">
        drug therapy
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D055808">
        Drug Discovery
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D004353">
        Drug Evaluation, Preclinical
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006801">
        Humans
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D065207">
        Middle East Respiratory Syndrome Coronavirus
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000187">
        drug effects
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D011024">
        Pneumonia, Viral
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000188">
        drug therapy
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D045473">
        SARS Virus
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000187">
        drug effects
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D012844">
        Sincalide
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D014709">
        Vero Cells
       </descriptorname>
      </meshheading>
     </meshheadinglist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2020
       </year>
       <month>
        01
       </month>
       <day>
        25
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        2020
       </year>
       <month>
        01
       </month>
       <day>
        28
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        2
       </month>
       <day>
        6
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        24
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        2
       </month>
       <day>
        6
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32020029
      </articleid>
      <articleid idtype="doi">
       10.1038/s41422-020-0282-0
      </articleid>
      <articleid idtype="pii">
       10.1038/s41422-020-0282-0
      </articleid>
      <articleid idtype="pmc">
       PMC7054408
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        Am J Med. 1983 Jul 18;75(1A):40-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         6869410
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Sci Transl Med. 2017 Jun 28;9(396):
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28659436
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Cell Res. 2013 Feb;23(2):300-2
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23208422
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2019 Dec 12;381(24):2293-2303
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31774950
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2020 Feb 15;395(10223):497-506
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31986264
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet Infect Dis. 2006 Feb;6(2):67-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16439323
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nat Rev Drug Discov. 2016 May;15(5):327-47
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26868298
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Antiviral Res. 2014 May;105:17-21
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24583123
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Virol J. 2005 Aug 22;2:69
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16115318
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nature. 2016 Mar 17;531(7594):381-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26934220
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32152082
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       03
      </month>
      <day>
       10
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1098-6596
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Mar
         </month>
         <day>
          09
         </day>
        </pubdate>
       </journalissue>
       <title>
        Antimicrobial agents and chemotherapy
       </title>
       <isoabbreviation>
        Antimicrob. Agents Chemother.
       </isoabbreviation>
      </journal>
      <articletitle>
       Compounds with therapeutic potential against novel respiratory 2019 coronavirus.
      </articletitle>
      <elocationid eidtype="pii" validyn="Y">
       AAC.00399-20
      </elocationid>
      <elocationid eidtype="doi" validyn="Y">
       10.1128/AAC.00399-20
      </elocationid>
      <abstract>
       <abstracttext>
        Currently, the expansion of the novel human respiratory coronavirus (known as: SARS-CoV-2, COVID-2019, or 2019-nCoV) has stressed the need for therapeutic alternatives to alleviate and stop this new epidemic. The previous epidemics of high-morbidity human coronaviruses, such as the acute respiratory syndrome coronavirus (SARS-CoV) in 2003, and the Middle East respiratory syndrome corona virus (MERS-CoV) in 2012, prompted the characterization of compounds that could be potentially active against the currently emerging novel coronavirus SARS-CoV-2. The most promising compound is remdesivir (GS-5734), a nucleotide analog prodrug currently in clinical trials for treating Ebola virus infections. Remdesivir inhibited the replication of SARS-CoV and MERS-CoV in tissue cultures, and it displayed efficacy in non-human animal models. In addition, a combination of the human immunodeficiency virus type 1 (HIV-1) protease inhibitors, lopinavir/ritonavir, and interferon beta (LPV/RTV-INFb) were shown to be effective in patients infected with SARS-CoV. LPV/RTV-INFb also improved clinical parameters in marmosets and mice infected with MERS-CoV. Remarkably, the therapeutic efficacy of remdesivir appeared to be superior to that of LPV/RTV-INFb against MERS-CoV in a transgenic humanized mice model. The relatively high mortality rates associated with these three novel human coronavirus infections, SARS-CoV, MERS-CoV, and SARS-CoV-2, has suggested that pro-inflammatory responses might play a role in the pathogenesis. It remains unknown whether the generated inflammatory state should be targeted. Therapeutics that target the coronavirus alone might not be able to reverse highly pathogenic infections. This minireview aimed to provide a summary of therapeutic compounds that showed potential in fighting SARS-CoV-2 infections.
       </abstracttext>
       <copyrightinformation>
        Copyright © 2020 American Society for Microbiology.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Martinez
        </lastname>
        <forename>
         Miguel Angel
        </forename>
        <initials>
         MA
        </initials>
        <identifier source="ORCID">
         https://orcid.org/0000-0002-6681-4950
        </identifier>
        <affiliationinfo>
         <affiliation>
          IrsiCaixa, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona (UAB), Badalona, Spain mmartinez@irsicaixa.es.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
       <publicationtype ui="D016454">
        Review
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        09
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       United States
      </country>
      <medlineta>
       Antimicrob Agents Chemother
      </medlineta>
      <nlmuniqueid>
       0315061
      </nlmuniqueid>
      <issnlinking>
       0066-4804
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        11
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        11
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        11
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32152082
      </articleid>
      <articleid idtype="pii">
       AAC.00399-20
      </articleid>
      <articleid idtype="doi">
       10.1128/AAC.00399-20
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="MEDLINE">
     <pmid version="1">
      32127666
     </pmid>
     <datecompleted>
      <year>
       2020
      </year>
      <month>
       03
      </month>
      <day>
       23
      </day>
     </datecompleted>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       03
      </month>
      <day>
       25
      </day>
     </daterevised>
     <article pubmodel="Print">
      <journal>
       <issn issntype="Electronic">
        1474-1784
       </issn>
       <journalissue citedmedium="Internet">
        <volume>
         19
        </volume>
        <issue>
         3
        </issue>
        <pubdate>
         <year>
          2020
         </year>
         <month>
          03
         </month>
        </pubdate>
       </journalissue>
       <title>
        Nature reviews. Drug discovery
       </title>
       <isoabbreviation>
        Nat Rev Drug Discov
       </isoabbreviation>
      </journal>
      <articletitle>
       Therapeutic options for the 2019 novel coronavirus (2019-nCoV).
      </articletitle>
      <pagination>
       <medlinepgn>
        149-150
       </medlinepgn>
      </pagination>
      <elocationid eidtype="doi" validyn="Y">
       10.1038/d41573-020-00016-0
      </elocationid>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Li
        </lastname>
        <forename>
         Guangdi
        </forename>
        <initials>
         G
        </initials>
       </author>
       <author validyn="Y">
        <lastname>
         De Clercq
        </lastname>
        <forename>
         Erik
        </forename>
        <initials>
         E
        </initials>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016433">
        News
       </publicationtype>
       <publicationtype ui="D013485">
        Research Support, Non-U.S. Gov't
       </publicationtype>
      </publicationtypelist>
     </article>
     <medlinejournalinfo>
      <country>
       England
      </country>
      <medlineta>
       Nat Rev Drug Discov
      </medlineta>
      <nlmuniqueid>
       101124171
      </nlmuniqueid>
      <issnlinking>
       1474-1776
      </issnlinking>
     </medlinejournalinfo>
     <chemicallist>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D000998">
        Antiviral Agents
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D016898">
        Interferon-alpha
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D009705">
        Nucleosides
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D011480">
        Protease Inhibitors
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D011994">
        Recombinant Proteins
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D064370">
        Spike Glycoprotein, Coronavirus
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        3QKI37EEHE
       </registrynumber>
       <nameofsubstance ui="C000606551">
        remdesivir
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        3WJQ0SDW1A
       </registrynumber>
       <nameofsubstance ui="D011092">
        Polyethylene Glycols
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        415SHH325A
       </registrynumber>
       <nameofsubstance ui="D000249">
        Adenosine Monophosphate
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        OF5P57N2ZX
       </registrynumber>
       <nameofsubstance ui="D000409">
        Alanine
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        Q46947FE7K
       </registrynumber>
       <nameofsubstance ui="C100416">
        peginterferon alfa-2a
       </nameofsubstance>
      </chemical>
     </chemicallist>
     <supplmeshlist>
      <supplmeshname type="Disease" ui="C000657245">
       COVID-19
      </supplmeshname>
      <supplmeshname type="Organism" ui="C000656484">
       severe acute respiratory syndrome coronavirus 2
      </supplmeshname>
     </supplmeshlist>
     <citationsubset>
      IM
     </citationsubset>
     <meshheadinglist>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000249">
        Adenosine Monophosphate
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000031">
        analogs &amp; derivatives
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000409">
        Alanine
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000031">
        analogs &amp; derivatives
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000998">
        Antiviral Agents
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="Y" ui="D000073640">
        Betacoronavirus
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000187">
        drug effects
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000235">
        genetics
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000472">
        pathogenicity
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D018352">
        Coronavirus Infections
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000188">
        drug therapy
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="Y" ui="D058492">
        Drug Repositioning
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D015658">
        HIV Infections
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000188">
        drug therapy
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006509">
        Hepatitis B
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000188">
        drug therapy
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006526">
        Hepatitis C
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000188">
        drug therapy
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006801">
        Humans
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D007251">
        Influenza, Human
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000188">
        drug therapy
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D016898">
        Interferon-alpha
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000494">
        pharmacology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D065207">
        Middle East Respiratory Syndrome Coronavirus
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000187">
        drug effects
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000235">
        genetics
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000472">
        pathogenicity
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="Y" ui="D009705">
        Nucleosides
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000494">
        pharmacology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D011024">
        Pneumonia, Viral
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000188">
        drug therapy
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D011092">
        Polyethylene Glycols
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000494">
        pharmacology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="Y" ui="D011480">
        Protease Inhibitors
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000494">
        pharmacology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D011994">
        Recombinant Proteins
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000494">
        pharmacology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D045473">
        SARS Virus
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000187">
        drug effects
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000235">
        genetics
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000472">
        pathogenicity
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D064370">
        Spike Glycoprotein, Coronavirus
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000187">
        drug effects
       </qualifiername>
      </meshheading>
     </meshheadinglist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        5
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        24
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        5
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32127666
      </articleid>
      <articleid idtype="doi">
       10.1038/d41573-020-00016-0
      </articleid>
      <articleid idtype="pii">
       10.1038/d41573-020-00016-0
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="MEDLINE">
     <pmid version="1">
      32094225
     </pmid>
     <datecompleted>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       15
      </day>
     </datecompleted>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       18
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1083-351X
       </issn>
       <journalissue citedmedium="Internet">
        <volume>
         295
        </volume>
        <issue>
         15
        </issue>
        <pubdate>
         <year>
          2020
         </year>
         <month>
          04
         </month>
         <day>
          10
         </day>
        </pubdate>
       </journalissue>
       <title>
        The Journal of biological chemistry
       </title>
       <isoabbreviation>
        J. Biol. Chem.
       </isoabbreviation>
      </journal>
      <articletitle>
       The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.
      </articletitle>
      <pagination>
       <medlinepgn>
        4773-4779
       </medlinepgn>
      </pagination>
      <elocationid eidtype="doi" validyn="Y">
       10.1074/jbc.AC120.013056
      </elocationid>
      <abstract>
       <abstracttext>
        Antiviral drugs for managing infections with human coronaviruses are not yet approved, posing a serious challenge to current global efforts aimed at containing the outbreak of severe acute respiratory syndrome-coronavirus 2 (CoV-2). Remdesivir (RDV) is an investigational compound with a broad spectrum of antiviral activities against RNA viruses, including severe acute respiratory syndrome-CoV and Middle East respiratory syndrome (MERS-CoV). RDV is a nucleotide analog inhibitor of RNA-dependent RNA polymerases (RdRps). Here, we co-expressed the MERS-CoV nonstructural proteins nsp5, nsp7, nsp8, and nsp12 (RdRp) in insect cells as a part a polyprotein to study the mechanism of inhibition of MERS-CoV RdRp by RDV. We initially demonstrated that nsp8 and nsp12 form an active complex. The triphosphate form of the inhibitor (RDV-TP) competes with its natural counterpart ATP. Of note, the selectivity value for RDV-TP obtained here with a steady-state approach suggests that it is more efficiently incorporated than ATP and two other nucleotide analogs. Once incorporated at position
        <i>
         i
        </i>
        , the inhibitor caused RNA synthesis arrest at position
        <i>
         i
        </i>
        + 3. Hence, the likely mechanism of action is delayed RNA chain termination. The additional three nucleotides may protect the inhibitor from excision by the viral 3'-5' exonuclease activity. Together, these results help to explain the high potency of RDV against RNA viruses in cell-based assays.
       </abstracttext>
       <copyrightinformation>
        © 2020 Gordon et al.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Gordon
        </lastname>
        <forename>
         Calvin J
        </forename>
        <initials>
         CJ
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Tchesnokov
        </lastname>
        <forename>
         Egor P
        </forename>
        <initials>
         EP
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2E1, Canada.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Feng
        </lastname>
        <forename>
         Joy Y
        </forename>
        <initials>
         JY
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Inc., Foster City, California 94404.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Porter
        </lastname>
        <forename>
         Danielle P
        </forename>
        <initials>
         DP
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Inc., Foster City, California 94404.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Götte
        </lastname>
        <forename>
         Matthias
        </forename>
        <initials>
         M
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta T6G 2E1, Canada gotte@ualberta.ca.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Li Ka Shing Institute of Virology at University of Alberta, Edmonton, Alberta T6G 2E1, Canada.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <grantlist completeyn="Y">
       <grant>
        <grantid>
         159507
        </grantid>
        <agency>
         CIHR
        </agency>
        <country>
         Canada
        </country>
       </grant>
      </grantlist>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
       <publicationtype ui="D013485">
        Research Support, Non-U.S. Gov't
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        02
       </month>
       <day>
        24
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       United States
      </country>
      <medlineta>
       J Biol Chem
      </medlineta>
      <nlmuniqueid>
       2985121R
      </nlmuniqueid>
      <issnlinking>
       0021-9258
      </issnlinking>
     </medlinejournalinfo>
     <chemicallist>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D000998">
        Antiviral Agents
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D019384">
        Nucleic Acid Synthesis Inhibitors
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="C034477">
        RNA primers
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D017361">
        Viral Nonstructural Proteins
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        3QKI37EEHE
       </registrynumber>
       <nameofsubstance ui="C000606551">
        remdesivir
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        415SHH325A
       </registrynumber>
       <nameofsubstance ui="D000249">
        Adenosine Monophosphate
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        63231-63-0
       </registrynumber>
       <nameofsubstance ui="D012313">
        RNA
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        EC 2.7.7.48
       </registrynumber>
       <nameofsubstance ui="D012324">
        RNA Replicase
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        OF5P57N2ZX
       </registrynumber>
       <nameofsubstance ui="D000409">
        Alanine
       </nameofsubstance>
      </chemical>
     </chemicallist>
     <citationsubset>
      IM
     </citationsubset>
     <meshheadinglist>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000249">
        Adenosine Monophosphate
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000031">
        analogs &amp; derivatives
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000737">
        chemistry
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000494">
        pharmacology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000409">
        Alanine
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000031">
        analogs &amp; derivatives
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000737">
        chemistry
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000494">
        pharmacology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000818">
        Animals
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000998">
        Antiviral Agents
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000737">
        chemistry
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000494">
        pharmacology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D017934">
        Coronavirus
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000201">
        enzymology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D029043">
        Ebolavirus
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000201">
        enzymology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D015870">
        Gene Expression
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D065207">
        Middle East Respiratory Syndrome Coronavirus
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000201">
        enzymology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D019384">
        Nucleic Acid Synthesis Inhibitors
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000737">
        chemistry
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000494">
        pharmacology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D012313">
        RNA
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D012324">
        RNA Replicase
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000037">
        antagonists &amp; inhibitors
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000235">
        genetics
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D061987">
        Sf9 Cells
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D017361">
        Viral Nonstructural Proteins
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000235">
        genetics
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D014779">
        Virus Replication
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000187">
        drug effects
       </qualifiername>
      </meshheading>
     </meshheadinglist>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="Y">
       Ebola virus (EBOV)
      </keyword>
      <keyword majortopicyn="Y">
       Middle East respiratory syndrome coronavirus (MERS–CoV)
      </keyword>
      <keyword majortopicyn="Y">
       RNA chain termination
      </keyword>
      <keyword majortopicyn="Y">
       RNA-dependent RNA polymerase (RdRp)
      </keyword>
      <keyword majortopicyn="Y">
       SARS–CoV-2
      </keyword>
      <keyword majortopicyn="Y">
       antiviral drug
      </keyword>
      <keyword majortopicyn="Y">
       coronavirus
      </keyword>
      <keyword majortopicyn="Y">
       drug development
      </keyword>
      <keyword majortopicyn="Y">
       enzyme inhibitor
      </keyword>
      <keyword majortopicyn="Y">
       nucleoside/nucleotide analog
      </keyword>
      <keyword majortopicyn="Y">
       plus-stranded RNA virus
      </keyword>
      <keyword majortopicyn="Y">
       positive-sense RNA virus
      </keyword>
      <keyword majortopicyn="Y">
       remdesivir
      </keyword>
      <keyword majortopicyn="Y">
       viral polymerase
      </keyword>
      <keyword majortopicyn="Y">
       viral replicase
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2020
       </year>
       <month>
        02
       </month>
       <day>
        14
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="revised">
       <year>
        2020
       </year>
       <month>
        02
       </month>
       <day>
        19
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        2
       </month>
       <day>
        26
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        16
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        2
       </month>
       <day>
        26
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32094225
      </articleid>
      <articleid idtype="pii">
       AC120.013056
      </articleid>
      <articleid idtype="doi">
       10.1074/jbc.AC120.013056
      </articleid>
      <articleid idtype="pmc">
       PMC7152756
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        Nat Biotechnol. 2004 Dec;22(12):1583-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15568020
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Trials. 2020 Jan 3;21(1):8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31900204
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Sci Transl Med. 2017 Jun 28;9(396):
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28659436
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):E162-E171
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29279395
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Antiviral Res. 2019 Sep;169:104541
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31233808
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Sci Rep. 2017 Mar 06;7:43395
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28262699
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Biol Chem. 2008 Dec 5;283(49):34218-28
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18940786
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Viruses. 2019 Apr 04;11(4):
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30987343
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2019 Dec 12;381(24):2293-2303
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31774950
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Antimicrob Agents Chemother. 2014 Aug;58(8):4875-84
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24841269
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        EMBO J. 1989 Dec 1;8(12):3867-74
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         2555175
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):E3900-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25197083
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Curr Protoc Protein Sci. 2008 Feb;Chapter 5:Unit 5.20
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18429060
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Sci Rep. 2018 Mar 5;8(1):3970
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29507309
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        PLoS Pathog. 2015 Jun 22;11(6):e1004995
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26098424
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Virol. 1999 Mar;73(3):2333-42
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         9971816
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Med Chem. 2017 Mar 9;60(5):1648-1661
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28124907
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nat Commun. 2019 May 28;10(1):2342
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31138817
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        EMBO J. 2006 Oct 18;25(20):4933-42
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17024178
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        mBio. 2018 Mar 6;9(2):
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29511076
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6771-6776
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32054787
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        PLoS Pathog. 2018 Feb 9;14(2):e1006889
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29425244
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        PLoS Pathog. 2012;8(10):e1002980
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23093940
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Cell Rep. 2017 Oct 24;21(4):1063-1076
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29069588
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nature. 2016 Mar 17;531(7594):381-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26934220
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nat Commun. 2020 Jan 10;11(1):222
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31924756
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="MEDLINE">
     <pmid version="1">
      32081636
     </pmid>
     <datecompleted>
      <year>
       2020
      </year>
      <month>
       03
      </month>
      <day>
       25
      </day>
     </datecompleted>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       09
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1872-7913
       </issn>
       <journalissue citedmedium="Internet">
        <volume>
         55
        </volume>
        <issue>
         3
        </issue>
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Mar
         </month>
        </pubdate>
       </journalissue>
       <title>
        International journal of antimicrobial agents
       </title>
       <isoabbreviation>
        Int. J. Antimicrob. Agents
       </isoabbreviation>
      </journal>
      <articletitle>
       Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.
      </articletitle>
      <pagination>
       <medlinepgn>
        105924
       </medlinepgn>
      </pagination>
      <elocationid eidtype="pii" validyn="Y">
       S0924-8579(20)30067-4
      </elocationid>
      <elocationid eidtype="doi" validyn="Y">
       10.1016/j.ijantimicag.2020.105924
      </elocationid>
      <abstract>
       <abstracttext>
        The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously provisionally named 2019 novel coronavirus or 2019-nCoV) disease (COVID-19) in China at the end of 2019 has caused a large global outbreak and is a major public health issue. As of 11 February 2020, data from the World Health Organization (WHO) have shown that more than 43 000 confirmed cases have been identified in 28 countries/regions, with &gt;99% of cases being detected in China. On 30 January 2020, the WHO declared COVID-19 as the sixth public health emergency of international concern. SARS-CoV-2 is closely related to two bat-derived severe acute respiratory syndrome-like coronaviruses, bat-SL-CoVZC45 and bat-SL-CoVZXC21. It is spread by human-to-human transmission via droplets or direct contact, and infection has been estimated to have mean incubation period of 6.4 days and a basic reproduction number of 2.24-3.58. Among patients with pneumonia caused by SARS-CoV-2 (novel coronavirus pneumonia or Wuhan pneumonia), fever was the most common symptom, followed by cough. Bilateral lung involvement with ground-glass opacity was the most common finding from computed tomography images of the chest. The one case of SARS-CoV-2 pneumonia in the USA is responding well to remdesivir, which is now undergoing a clinical trial in China. Currently, controlling infection to prevent the spread of SARS-CoV-2 is the primary intervention being used. However, public health authorities should keep monitoring the situation closely, as the more we can learn about this novel virus and its associated outbreak, the better we can respond.
       </abstracttext>
       <copyrightinformation>
        Copyright © 2020 Elsevier Ltd. All rights reserved.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Lai
        </lastname>
        <forename>
         Chih-Cheng
        </forename>
        <initials>
         CC
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Internal Medicine, Kaohsiung Veterans General Hospital, Tainan Branch, Tainan, Taiwan.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Shih
        </lastname>
        <forename>
         Tzu-Ping
        </forename>
        <initials>
         TP
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Family Medicine, Kaohsiung Veterans General Hospital, Tainan Branch, Tainan, Taiwan.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Ko
        </lastname>
        <forename>
         Wen-Chien
        </forename>
        <initials>
         WC
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Tang
        </lastname>
        <forename>
         Hung-Jen
        </forename>
        <initials>
         HJ
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Medicine, Chi Mei Medical Center, Tainan 71004, Taiwan.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Hsueh
        </lastname>
        <forename>
         Po-Ren
        </forename>
        <initials>
         PR
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: hsporen@ntu.edu.tw.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        02
       </month>
       <day>
        17
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       Netherlands
      </country>
      <medlineta>
       Int J Antimicrob Agents
      </medlineta>
      <nlmuniqueid>
       9111860
      </nlmuniqueid>
      <issnlinking>
       0924-8579
      </issnlinking>
     </medlinejournalinfo>
     <supplmeshlist>
      <supplmeshname type="Disease" ui="C000657245">
       COVID-19
      </supplmeshname>
      <supplmeshname type="Organism" ui="C000656484">
       severe acute respiratory syndrome coronavirus 2
      </supplmeshname>
     </supplmeshlist>
     <citationsubset>
      IM
     </citationsubset>
     <meshheadinglist>
      <meshheading>
       <descriptorname majortopicyn="Y" ui="D000073640">
        Betacoronavirus
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" type="Geographic" ui="D002681">
        China
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="Y" ui="D018352">
        Coronavirus Infections
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000453">
        epidemiology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000821">
        virology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D004196">
        Disease Outbreaks
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006801">
        Humans
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="Y" ui="D011024">
        Pneumonia, Viral
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000453">
        epidemiology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000821">
        virology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D045169">
        Severe Acute Respiratory Syndrome
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000821">
        virology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D014944">
        World Health Organization
       </descriptorname>
      </meshheading>
     </meshheadinglist>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       2019-nCoV
      </keyword>
      <keyword majortopicyn="N">
       COVID-19
      </keyword>
      <keyword majortopicyn="N">
       China
      </keyword>
      <keyword majortopicyn="N">
       Epidemic
      </keyword>
      <keyword majortopicyn="N">
       Remdesivir
      </keyword>
      <keyword majortopicyn="N">
       SARS-CoV-2
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2020
       </year>
       <month>
        02
       </month>
       <day>
        11
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="revised">
       <year>
        2020
       </year>
       <month>
        02
       </month>
       <day>
        12
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        2020
       </year>
       <month>
        02
       </month>
       <day>
        12
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        2
       </month>
       <day>
        23
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        26
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        2
       </month>
       <day>
        22
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32081636
      </articleid>
      <articleid idtype="pii">
       S0924-8579(20)30067-4
      </articleid>
      <articleid idtype="doi">
       10.1016/j.ijantimicag.2020.105924
      </articleid>
      <articleid idtype="pmc">
       PMC7127800
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        J Korean Med Sci. 2020 Feb 03;35(4):e56
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31997618
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Microbes Infect. 2020 Dec;9(1):221-236
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31987001
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Korean Med Sci. 2020 Feb 10;35(5):e61
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32030925
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Microbiol Immunol Infect. 2019 Apr;52(2):365-366
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29958866
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Microbiol Immunol Infect. 2019 Apr;52(2):215-224
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30172758
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Microbes Infect. 2020 Dec;9(1):313-319
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32020836
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Int J Infect Dis. 2020 Mar;92:214-217
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32007643
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Microbiol Immunol Infect. 2019 Dec;52(6):920-928
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31806539
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2020 Feb 15;395(10223):507-513
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32007143
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Microbes Infect. 2020 Dec;9(1):275-277
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32005086
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        MMWR Morb Mortal Wkly Rep. 2020 Feb 07;69(5):140-146
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32027631
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2020 Feb 15;395(10223):470-473
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31986257
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Microbiol Immunol Infect. 2019 Feb;52(1):172-199
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30612923
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Int J Antimicrob Agents. 2007 Oct;30(4):297-308
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17629679
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Appl Environ Microbiol. 2010 May;76(9):2712-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         20228108
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Microbiol Immunol Infect. 2019 Oct;52(5):838-839
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31337539
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Microbiol Immunol Infect. 2019 Apr;52(2):233-241
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30201131
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2020 Feb 15;395(10223):497-506
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31986264
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Am J Respir Crit Care Med. 2020 Feb 15;201(4):P7-P8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32004066
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2020 Feb 15;395(10223):473-475
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32043983
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation indexingmethod="Curated" owner="NLM" status="MEDLINE">
     <pmid version="1">
      32164081
     </pmid>
     <datecompleted>
      <year>
       2020
      </year>
      <month>
       03
      </month>
      <day>
       20
      </day>
     </datecompleted>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       03
      </month>
      <day>
       25
      </day>
     </daterevised>
     <article pubmodel="Print">
      <journal>
       <issn issntype="Print">
        1001-0939
       </issn>
       <journalissue citedmedium="Print">
        <volume>
         43
        </volume>
        <issue>
         3
        </issue>
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Mar
         </month>
         <day>
          12
         </day>
        </pubdate>
       </journalissue>
       <title>
        Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
       </title>
       <isoabbreviation>
        Zhonghua Jie He He Hu Xi Za Zhi
       </isoabbreviation>
      </journal>
      <articletitle>
       [Pharmacotherapeutics for the new coronavirus pneumonia].
      </articletitle>
      <pagination>
       <medlinepgn>
        173-176
       </medlinepgn>
      </pagination>
      <elocationid eidtype="doi" validyn="Y">
       10.3760/cma.j.issn.1001-0939.2020.03.005
      </elocationid>
      <abstract>
       <abstracttext>
        The new coronavirus pneumonia (NCP), also named as COVID-19 by WHO on Feb 11 2020, is now causing a severe public health emergency in China since. The number of diagnosed cases is more than 40,000 until the submission of this manuscript. Coronavirus has caused several epidemic situations world widely, but the present contagious disease caused by 2019 new coronavirus is unprecedentedly fulminating. The published cohorts of 2019 new coronavirus (n-Cov) are single-center studies, or retrospective studies. We here share the therapeutic experiences of NCP treatment with literature review. Combination of Ribavirin and interferon-α is recommended by the 5(th) edition National Health Commission's Regimen (Revised Edition) because of the effect on Middle East respiratory syndrome (MERS), and the effectiveness of Lopinavir/Ritonavir and Remdisivir needs to be confirmed by randomized controlled trial (RCT), given the situation of no specific antivirus drug on NCP is unavailable. Systemic glucocorticosteroid is recommended as a short term use (1~2 mg·kg(-1)·d(-1), 3~5 d) by the 5(th) edition National Health Commission's Regimen (Revised Edition) yet RCTs are expected to confirm the effectiveness. Inappropriate application of antibiotics should be avoided, especially the combination of broad-spectrum antibiotics, for the NCP is not often complicated with bacterial infection.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Du
        </lastname>
        <forename>
         B
        </forename>
        <initials>
         B
        </initials>
        <affiliationinfo>
         <affiliation>
          Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College &amp; Chinese Academy of Medical Sciences, Beijing 100730, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Qiu
        </lastname>
        <forename>
         H B
        </forename>
        <initials>
         HB
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Zhan
        </lastname>
        <forename>
         X
        </forename>
        <initials>
         X
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wang
        </lastname>
        <forename>
         Y S
        </forename>
        <initials>
         YS
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Kang
        </lastname>
        <forename>
         H Y J
        </forename>
        <initials>
         HYJ
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Li
        </lastname>
        <forename>
         X Y
        </forename>
        <initials>
         XY
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wang
        </lastname>
        <forename>
         F
        </forename>
        <initials>
         F
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Sun
        </lastname>
        <forename>
         B
        </forename>
        <initials>
         B
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Tong
        </lastname>
        <forename>
         Z H
        </forename>
        <initials>
         ZH
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-yang Hospital, Capital Medical University, Beijing 100020, China.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       chi
      </language>
      <grantlist completeyn="Y">
       <grant>
        <grantid>
         2020YFC0841300
        </grantid>
        <agency>
         Ministry of Science and Technology emergency response project to pneumonia pandemic of novel coronavirus infection
        </agency>
        <country>
        </country>
       </grant>
      </grantlist>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
       <publicationtype ui="D016454">
        Review
       </publicationtype>
      </publicationtypelist>
     </article>
     <medlinejournalinfo>
      <country>
       China
      </country>
      <medlineta>
       Zhonghua Jie He He Hu Xi Za Zhi
      </medlineta>
      <nlmuniqueid>
       8712226
      </nlmuniqueid>
      <issnlinking>
       1001-0939
      </issnlinking>
     </medlinejournalinfo>
     <chemicallist>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D000900">
        Anti-Bacterial Agents
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D000998">
        Antiviral Agents
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D065692">
        Cytochrome P-450 CYP3A Inhibitors
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D012265">
        Ribonucleotides
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        2494G1JF75
       </registrynumber>
       <nameofsubstance ui="D061466">
        Lopinavir
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        3QKI37EEHE
       </registrynumber>
       <nameofsubstance ui="C000606551">
        remdesivir
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        K72T3FS567
       </registrynumber>
       <nameofsubstance ui="D000241">
        Adenosine
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        O3J8G9O825
       </registrynumber>
       <nameofsubstance ui="D019438">
        Ritonavir
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        OF5P57N2ZX
       </registrynumber>
       <nameofsubstance ui="D000409">
        Alanine
       </nameofsubstance>
      </chemical>
     </chemicallist>
     <supplmeshlist>
      <supplmeshname type="Disease" ui="C000657245">
       COVID-19
      </supplmeshname>
     </supplmeshlist>
     <citationsubset>
      IM
     </citationsubset>
     <meshheadinglist>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000241">
        Adenosine
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000031">
        analogs &amp; derivatives
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000409">
        Alanine
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000031">
        analogs &amp; derivatives
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000900">
        Anti-Bacterial Agents
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="Y" ui="D000998">
        Antiviral Agents
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" type="Geographic" ui="D002681">
        China
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D018352">
        Coronavirus Infections
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000188">
        drug therapy
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D065692">
        Cytochrome P-450 CYP3A Inhibitors
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D004359">
        Drug Therapy, Combination
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006801">
        Humans
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D061466">
        Lopinavir
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D011024">
        Pneumonia, Viral
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000188">
        drug therapy
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D012189">
        Retrospective Studies
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D012265">
        Ribonucleotides
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D019438">
        Ritonavir
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
     </meshheadinglist>
     <otherabstract language="chi" type="Publisher">
      <abstracttext>
       新型冠状病毒肺炎（new coronavirus pneumonia，NCP）正在中国引起严重疫情，截至发稿之日，全国确诊人数已逾4万。冠状病毒已经在全世界范围内引起数次疫情，但此次疫情的来势之迅猛及传染性之强前所未有。我们对引起此次疫情的病原体——2019新型冠状病毒知之甚少，目前在国际上发表的临床研究文章或为单中心研究，或为回顾性分析。我们结合在新冠肺炎一线的救治体会及相关发表的研究成果，给大家分享新冠肺炎的治疗经验。抗病毒药物方面，目前仍无特效药物，利巴韦林和干扰素联合用药由于其治疗中东呼吸综合征（MERS）有效，仍被我国新冠肺炎诊疗方案推荐；洛匹那韦/利托那韦和瑞德西韦的疗效有待随机对照临床试验（randomized controlled trial，RCT）评价；糖皮质激素的短期应用（1~2 mg·kg(-1)·d(-1)，3~5 d）被我国诊疗方案推荐，但仍需RCT进一步证实；本次新冠肺炎合并细菌感染较少，应当避免盲目使用抗菌药物，尤其避免联用广谱抗菌药物。.
      </abstracttext>
     </otherabstract>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       Antibiotics
      </keyword>
      <keyword majortopicyn="N">
       Glucocorticosteroid
      </keyword>
      <keyword majortopicyn="N">
       New coronavirus pneumonia
      </keyword>
      <keyword majortopicyn="N">
       Pharmacotherapeutics
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        13
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        14
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        21
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32164081
      </articleid>
      <articleid idtype="doi">
       10.3760/cma.j.issn.1001-0939.2020.03.005
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32247050
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       07
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1878-3511
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          01
         </day>
        </pubdate>
       </journalissue>
       <title>
        International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
       </title>
       <isoabbreviation>
        Int. J. Infect. Dis.
       </isoabbreviation>
      </journal>
      <articletitle>
       Insight into 2019 novel coronavirus - an updated intrim review and lessons from SARS-CoV and MERS-CoV.
      </articletitle>
      <elocationid eidtype="pii" validyn="Y">
       S1201-9712(20)30204-6
      </elocationid>
      <elocationid eidtype="doi" validyn="Y">
       10.1016/j.ijid.2020.03.071
      </elocationid>
      <abstract>
       <abstracttext label="BACKGROUND" nlmcategory="BACKGROUND">
        The rapid spread of the coronavirus disease 2019 (COVID-19), caused by a zoonotic beta-coronavirus entitled 2019 novel coronavirus (2019-nCoV), has become a global threat. Awareness of the biological features of 2019-nCoV should be updated in time and needs to be comprehensively summarized to help optimize control measures and make therapeutic decisions.
       </abstracttext>
       <abstracttext label="METHODS" nlmcategory="METHODS">
        Based on recently published literatures, official documents and selected up-to-date preprint studies, we reviewed the virology and origin, epidemiology, clinical manifestations, pathology and treatment of 2019-nCoV infection, in comparison with severe acute respiratory syndrome coronavirus (SARS-CoV) and middle east respiratory syndrome coronavirus (MERS-CoV) infection.
       </abstracttext>
       <abstracttext label="RESULTS" nlmcategory="RESULTS">
        The genome of 2019-nCoV partially resembled SARS-CoV and MERS-CoV, and indicating a bat origin. The COVID-19 generally had a high reproductive number, a long incubation period, a short serial interval and a low case fatality rate (much higher in patients with comorbidities) than SARS and MERS. Clinical presentation and pathology of COVID-19 greatly resembled SARS and MERS, with less upper respiratory and gastrointestinal symptoms, and more exudative lesions in post-mortems. Potential treatments included remdesivir, chloroquine, tocilizumab, convalescent plasma and vaccine immunization (when possible).
       </abstracttext>
       <abstracttext label="CONCLUSION" nlmcategory="CONCLUSIONS">
        The initial experience from the current pandemic and lessons from the previous two pandemics can help improve future preparedness plans and combat disease progression.
       </abstracttext>
       <copyrightinformation>
        Copyright © 2020. Published by Elsevier Ltd.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Xie
        </lastname>
        <forename>
         Mingxuan
        </forename>
        <initials>
         M
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Geriatrics / Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Chen
        </lastname>
        <forename>
         Qiong
        </forename>
        <initials>
         Q
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Geriatrics / Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, 410008, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China. Electronic address: qiongch@163.com.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
       <publicationtype ui="D016454">
        Review
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        01
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       Canada
      </country>
      <medlineta>
       Int J Infect Dis
      </medlineta>
      <nlmuniqueid>
       9610933
      </nlmuniqueid>
      <issnlinking>
       1201-9712
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       2019-nCoV
      </keyword>
      <keyword majortopicyn="N">
       COVID-19
      </keyword>
      <keyword majortopicyn="N">
       MERS-CoV
      </keyword>
      <keyword majortopicyn="N">
       SARS-CoV
      </keyword>
      <keyword majortopicyn="N">
       SARS-CoV-2
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        08
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="revised">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        23
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        24
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        5
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        5
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        5
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32247050
      </articleid>
      <articleid idtype="pii">
       S1201-9712(20)30204-6
      </articleid>
      <articleid idtype="doi">
       10.1016/j.ijid.2020.03.071
      </articleid>
      <articleid idtype="pmc">
       PMC7118633
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        Science. 2003 Jun 20;300(5627):1966-70
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12766207
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Clin Rev Allergy Immunol. 2019 Jun;56(3):308-321
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28963611
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Cell Res. 2020 Mar;30(3):269-271
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32020029
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Euro Surveill. 2015 Jun 25;20(25):7-13
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26132767
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Infect Dis. 2015 Jan 1;211(1):80-90
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25030060
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2019 Dec 12;381(24):2293-2303
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31774950
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2020 Feb 15;395(10223):497-506
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31986264
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2020 Feb 15;395(10223):507-513
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32007143
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2003 May 24;361(9371):1773-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12781536
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2536-41
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         14983044
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet Infect Dis. 2009 May;9(5):291-300
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19393959
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Emerg Microbes Infect. 2020 Dec;9(1):221-236
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31987001
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        BMC Public Health. 2018 May 2;18(1):574
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29716568
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2020 Feb 20;382(8):727-733
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31978945
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Oncologist. 2018 Aug;23(8):943-947
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29622697
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Med Virol. 2020 Apr;92(4):433-440
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31967321
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2013 Aug 24;382(9893):662-4
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23831143
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet Infect Dis. 2013 Sep;13(9):752-61
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23891402
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2003 Apr 3;348(14):1322-32
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12672859
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2016 Jan 7;374(1):33-42
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26735992
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Int J Infect Dis. 2016 Aug;49:129-33
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27352628
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Epidemiology. 2005 Nov;16(6):791-801
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16222170
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Virol J. 2005 Aug 22;2:69
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16115318
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nat Commun. 2020 Jan 10;11(1):222
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31924756
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="MEDLINE">
     <pmid version="1">
      32054787
     </pmid>
     <datecompleted>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       01
      </day>
     </datecompleted>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       03
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1091-6490
       </issn>
       <journalissue citedmedium="Internet">
        <volume>
         117
        </volume>
        <issue>
         12
        </issue>
        <pubdate>
         <year>
          2020
         </year>
         <month>
          03
         </month>
         <day>
          24
         </day>
        </pubdate>
       </journalissue>
       <title>
        Proceedings of the National Academy of Sciences of the United States of America
       </title>
       <isoabbreviation>
        Proc. Natl. Acad. Sci. U.S.A.
       </isoabbreviation>
      </journal>
      <articletitle>
       Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
      </articletitle>
      <pagination>
       <medlinepgn>
        6771-6776
       </medlinepgn>
      </pagination>
      <elocationid eidtype="doi" validyn="Y">
       10.1073/pnas.1922083117
      </elocationid>
      <abstract>
       <abstracttext>
        The continued emergence of Middle East Respiratory Syndrome (MERS) cases with a high case fatality rate stresses the need for the availability of effective antiviral treatments. Remdesivir (GS-5734) effectively inhibited MERS coronavirus (MERS-CoV) replication in vitro, and showed efficacy against Severe Acute Respiratory Syndrome (SARS)-CoV in a mouse model. Here, we tested the efficacy of prophylactic and therapeutic remdesivir treatment in a nonhuman primate model of MERS-CoV infection, the rhesus macaque. Prophylactic remdesivir treatment initiated 24 h prior to inoculation completely prevented MERS-CoV-induced clinical disease, strongly inhibited MERS-CoV replication in respiratory tissues, and prevented the formation of lung lesions. Therapeutic remdesivir treatment initiated 12 h postinoculation also provided a clear clinical benefit, with a reduction in clinical signs, reduced virus replication in the lungs, and decreased presence and severity of lung lesions. The data presented here support testing of the efficacy of remdesivir treatment in the context of a MERS clinical trial. It may also be considered for a wider range of coronaviruses, including the currently emerging novel coronavirus 2019-nCoV.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         de Wit
        </lastname>
        <forename>
         Emmie
        </forename>
        <initials>
         E
        </initials>
        <identifier source="ORCID">
         0000-0002-9763-7758
        </identifier>
        <affiliationinfo>
         <affiliation>
          Laboratory of Virology, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, MT 59840; Emmie.deWit@nih.gov.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Feldmann
        </lastname>
        <forename>
         Friederike
        </forename>
        <initials>
         F
        </initials>
        <affiliationinfo>
         <affiliation>
          Rocky Mountain Veterinary Branch, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, MT 59840.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Cronin
        </lastname>
        <forename>
         Jacqueline
        </forename>
        <initials>
         J
        </initials>
        <affiliationinfo>
         <affiliation>
          Laboratory of Virology, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, MT 59840.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Jordan
        </lastname>
        <forename>
         Robert
        </forename>
        <initials>
         R
        </initials>
        <affiliationinfo>
         <affiliation>
          Biology Department, Gilead Sciences, Foster City, CA 94404.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Okumura
        </lastname>
        <forename>
         Atsushi
        </forename>
        <initials>
         A
        </initials>
        <affiliationinfo>
         <affiliation>
          Center for Infection and Immunity, Mailman School of Public Health, Columbia University, New York, NY 10032.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Thomas
        </lastname>
        <forename>
         Tina
        </forename>
        <initials>
         T
        </initials>
        <affiliationinfo>
         <affiliation>
          Laboratory of Virology, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, MT 59840.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Scott
        </lastname>
        <forename>
         Dana
        </forename>
        <initials>
         D
        </initials>
        <affiliationinfo>
         <affiliation>
          Rocky Mountain Veterinary Branch, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, MT 59840.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Cihlar
        </lastname>
        <forename>
         Tomas
        </forename>
        <initials>
         T
        </initials>
        <affiliationinfo>
         <affiliation>
          Biology Department, Gilead Sciences, Foster City, CA 94404.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Feldmann
        </lastname>
        <forename>
         Heinz
        </forename>
        <initials>
         H
        </initials>
        <affiliationinfo>
         <affiliation>
          Laboratory of Virology, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, MT 59840.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
       <publicationtype ui="D052060">
        Research Support, N.I.H., Intramural
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        02
       </month>
       <day>
        13
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       United States
      </country>
      <medlineta>
       Proc Natl Acad Sci U S A
      </medlineta>
      <nlmuniqueid>
       7505876
      </nlmuniqueid>
      <issnlinking>
       0027-8424
      </issnlinking>
     </medlinejournalinfo>
     <chemicallist>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D000998">
        Antiviral Agents
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        3QKI37EEHE
       </registrynumber>
       <nameofsubstance ui="C000606551">
        remdesivir
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        415SHH325A
       </registrynumber>
       <nameofsubstance ui="D000249">
        Adenosine Monophosphate
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        OF5P57N2ZX
       </registrynumber>
       <nameofsubstance ui="D000409">
        Alanine
       </nameofsubstance>
      </chemical>
     </chemicallist>
     <supplmeshlist>
      <supplmeshname type="Disease" ui="C000657245">
       COVID-19
      </supplmeshname>
      <supplmeshname type="Organism" ui="C000656484">
       severe acute respiratory syndrome coronavirus 2
      </supplmeshname>
     </supplmeshlist>
     <citationsubset>
      IM
     </citationsubset>
     <meshheadinglist>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000249">
        Adenosine Monophosphate
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000031">
        analogs &amp; derivatives
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000494">
        pharmacology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000409">
        Alanine
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000031">
        analogs &amp; derivatives
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000494">
        pharmacology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000818">
        Animals
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000998">
        Antiviral Agents
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000494">
        pharmacology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000073640">
        Betacoronavirus
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D018352">
        Coronavirus Infections
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000188">
        drug therapy
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000517">
        prevention &amp; control
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D004195">
        Disease Models, Animal
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D008168">
        Lung
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000473">
        pathology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000821">
        virology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D008253">
        Macaca mulatta
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D008297">
        Male
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D065207">
        Middle East Respiratory Syndrome Coronavirus
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000187">
        drug effects
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000502">
        physiology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D058873">
        Pandemics
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D011024">
        Pneumonia, Viral
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D056990">
        Post-Exposure Prophylaxis
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D019562">
        Viral Load
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D014779">
        Virus Replication
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000187">
        drug effects
       </qualifiername>
      </meshheading>
     </meshheadinglist>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="Y">
       MERS-CoV
      </keyword>
      <keyword majortopicyn="Y">
       animal model
      </keyword>
      <keyword majortopicyn="Y">
       antiviral
      </keyword>
      <keyword majortopicyn="Y">
       remdesivir
      </keyword>
      <keyword majortopicyn="Y">
       therapy
      </keyword>
     </keywordlist>
     <coistatement>
      Competing interest statement: The authors affiliated with Gilead Sciences are employees of the company and may own company stock; R.J. holds a patent on the use of remdesivir to treat Filovirus infections. The authors affiliated with NIH have no conflict of interest to report.
     </coistatement>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        2
       </month>
       <day>
        15
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        2
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        2
       </month>
       <day>
        15
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32054787
      </articleid>
      <articleid idtype="pii">
       1922083117
      </articleid>
      <articleid idtype="doi">
       10.1073/pnas.1922083117
      </articleid>
      <articleid idtype="pmc">
       PMC7104368
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        Emerg Infect Dis. 2019 Apr;25(4):753-766
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30882305
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Antiviral Res. 2017 Jul;143:30-37
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28389142
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nat Med. 2013 Oct;19(10):1313-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24013700
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Euro Surveill. 2012 Sep 27;17(39):
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23041020
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet Infect Dis. 2013 Sep;13(9):752-61
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23891402
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2019 Dec 12;381(24):2293-2303
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31774950
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        PLoS Pathog. 2014 Aug 21;10(8):e1004250
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25144235
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Sci Transl Med. 2019 May 29;11(494):
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31142680
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Front Immunol. 2018 Feb 12;9:205
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29483914
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16598-603
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24062443
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2017 Jan 21;389(10066):233-235
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28109539
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Infect Dis. 2015 Dec 15;212(12):1904-13
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26198719
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Sci Transl Med. 2017 Jun 28;9(396):
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28659436
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nat Med. 2016 Jul 7;22(7):701-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27387881
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Sci Rep. 2017 Mar 06;7:43395
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28262699
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Infect Dis. 2017 Jun 15;215(12):1807-1815
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28472421
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet Infect Dis. 2018 Aug;18(8):e217-e227
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29680581
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        mBio. 2018 Mar 6;9(2):
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29511076
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Comp Med. 2010 Oct;60(5):389-95
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21262125
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Infect Dis. 2017 Jan 15;215(2):171-174
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28073857
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nature. 2016 Mar 17;531(7594):381-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26934220
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nat Commun. 2020 Jan 10;11(1):222
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31924756
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2016 Jul 30;388(10043):498-503
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27209148
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Clin Infect Dis. 2016 Mar 15;62(6):755-60
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26679623
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Antiviral Res. 2018 Aug;156:64-71
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29885377
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32023685
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       02
      </month>
      <day>
       05
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Print">
        1001-0939
       </issn>
       <journalissue citedmedium="Print">
        <volume>
         43
        </volume>
        <issue>
         0
        </issue>
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Feb
         </month>
         <day>
          05
         </day>
        </pubdate>
       </journalissue>
       <title>
        Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
       </title>
       <isoabbreviation>
        Zhonghua Jie He He Hu Xi Za Zhi
       </isoabbreviation>
      </journal>
      <articletitle>
       [Potential antiviral therapeutics for 2019 Novel Coronavirus].
      </articletitle>
      <pagination>
       <medlinepgn>
        E002
       </medlinepgn>
      </pagination>
      <elocationid eidtype="doi" validyn="Y">
       10.3760/cma.j.issn.1001-0939.2020.0002
      </elocationid>
      <abstract>
       <abstracttext>
        The recent outbreak of respiratory illness in Wuhan, China is caused by a novel coronavirus, named 2019-nCoV, which is genetically close to a bat-derived coronavirus. 2019-nCoV is categorized as beta genus coronavirus, same as the two other strains - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Antiviral drugs commonly used in clinical practice, including neuraminidase inhibitors (oseltamivir, paramivir, zanamivir, etc.), ganciclovir, acyclovir and ribavirin, are invalid for 2019-nCoV and not recommended. Drugs are possibly effective for 2019-nCoV include: remdesivir, lopinavir / ritonavir, lopinavir / ritonavir combined with interferon-β, convalescent plasma, and monoclonal antibodies. But the efficacy and safety of these drugs for 2019-nCoV pneumonia patients need to be assessed by further clinical trials.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Li
        </lastname>
        <forename>
         H
        </forename>
        <initials>
         H
        </initials>
        <affiliationinfo>
         <affiliation>
          Center of Respiratory Medicine, China-Japan Friendship Hospital; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; National Clinical Research Center for Respiratory Diseases, Beijing 100020, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wang
        </lastname>
        <forename>
         Y M
        </forename>
        <initials>
         YM
        </initials>
        <affiliationinfo>
         <affiliation>
          Center of Respiratory Medicine, China-Japan Friendship Hospital; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; National Clinical Research Center for Respiratory Diseases, Beijing 100020, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Xu
        </lastname>
        <forename>
         J Y
        </forename>
        <initials>
         JY
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Basic Medical Sciences, Tsinghua University School of Medicine, Beijing 100084, China.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Cao
        </lastname>
        <forename>
         B
        </forename>
        <initials>
         B
        </initials>
        <affiliationinfo>
         <affiliation>
          Center of Respiratory Medicine, China-Japan Friendship Hospital; Institute of Respiratory Medicine, Chinese Academy of Medical Sciences; National Clinical Research Center for Respiratory Diseases, Beijing 100020, China.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       chi
      </language>
      <publicationtypelist>
       <publicationtype ui="D004740">
        English Abstract
       </publicationtype>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        02
       </month>
       <day>
        05
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       China
      </country>
      <medlineta>
       Zhonghua Jie He He Hu Xi Za Zhi
      </medlineta>
      <nlmuniqueid>
       8712226
      </nlmuniqueid>
      <issnlinking>
       1001-0939
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
     <otherabstract language="chi" type="Publisher">
      <abstracttext>
       2019新型冠状病毒(2019-nCoV)是武汉不明原因肺炎的致病原。2019-nCoV在遗传学上与一种蝙蝠来源的新型冠状病毒比较接近，与SARS-CoV、MERS-CoV同为β属冠状病毒。目前临床上常用的抗病毒药物，包括神经氨酸酶抑制剂（奥司他韦、帕拉米韦、扎那米韦等）、更昔洛韦、阿昔洛韦、利巴韦林等药物对2019-nCoV均无效，不建议临床应用。目前研究证实可能有效的药物包括：瑞德西韦、洛匹那韦/利托那韦、洛匹那韦/利托那韦联合干扰素-β、恢复期血浆、单克隆抗体。但这些药物在2019-nCoV肺炎患者中的疗效和安全性有待进一步临床实验证实。.
      </abstracttext>
     </otherabstract>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       2019 novel coronavirus
      </keyword>
      <keyword majortopicyn="N">
       Antiviral therapy
      </keyword>
      <keyword majortopicyn="N">
       Infection
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        2
       </month>
       <day>
        6
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        2
       </month>
       <day>
        6
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        2
       </month>
       <day>
        6
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32023685
      </articleid>
      <articleid idtype="doi">
       10.3760/cma.j.issn.1001-0939.2020.0002
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="MEDLINE">
     <pmid version="1">
      31996494
     </pmid>
     <datecompleted>
      <year>
       2020
      </year>
      <month>
       03
      </month>
      <day>
       18
      </day>
     </datecompleted>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       10
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1881-7823
       </issn>
       <journalissue citedmedium="Internet">
        <volume>
         14
        </volume>
        <issue>
         1
        </issue>
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Mar
         </month>
         <day>
          16
         </day>
        </pubdate>
       </journalissue>
       <title>
        Bioscience trends
       </title>
       <isoabbreviation>
        Biosci Trends
       </isoabbreviation>
      </journal>
      <articletitle>
       Drug treatment options for the 2019-new coronavirus (2019-nCoV).
      </articletitle>
      <pagination>
       <medlinepgn>
        69-71
       </medlinepgn>
      </pagination>
      <elocationid eidtype="doi" validyn="Y">
       10.5582/bst.2020.01020
      </elocationid>
      <abstract>
       <abstracttext>
        As of January 22, 2020, a total of 571 cases of the 2019-new coronavirus (2019-nCoV) have been reported in 25 provinces (districts and cities) in China. At present, there is no vaccine or antiviral treatment for human and animal coronavirus, so that identifying the drug treatment options as soon as possible is critical for the response to the 2019-nCoV outbreak. Three general methods, which include existing broad-spectrum antiviral drugs using standard assays, screening of a chemical library containing many existing compounds or databases, and the redevelopment of new specific drugs based on the genome and biophysical understanding of individual coronaviruses, are used to discover the potential antiviral treatment of human pathogen coronavirus. Lopinavir /Ritonavir, Nucleoside analogues, Neuraminidase inhibitors, Remdesivir, peptide (EK1), abidol, RNA synthesis inhibitors (such as TDF, 3TC), anti-inflammatory drugs (such as hormones and other molecules), Chinese traditional medicine, such ShuFengJieDu Capsules and Lianhuaqingwen Capsule, could be the drug treatment options for 2019-nCoV. However, the efficacy and safety of these drugs for 2019- nCoV still need to be further confirmed by clinical experiments.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Lu
        </lastname>
        <forename>
         Hongzhou
        </forename>
        <initials>
         H
        </initials>
        <affiliationinfo>
         <affiliation>
          Scientific Research Center, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Department of Infectious Diseases, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Department of Infectious Disease, Huashan Hospital Affiliated to Fudan University, Shanghai, China.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        01
       </month>
       <day>
        28
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       Japan
      </country>
      <medlineta>
       Biosci Trends
      </medlineta>
      <nlmuniqueid>
       101502754
      </nlmuniqueid>
      <issnlinking>
       1881-7815
      </issnlinking>
     </medlinejournalinfo>
     <chemicallist>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D000998">
        Antiviral Agents
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D004338">
        Drug Combinations
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D009705">
        Nucleosides
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D012265">
        Ribonucleotides
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="C558899">
        lopinavir-ritonavir drug combination
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        2494G1JF75
       </registrynumber>
       <nameofsubstance ui="D061466">
        Lopinavir
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        3QKI37EEHE
       </registrynumber>
       <nameofsubstance ui="C000606551">
        remdesivir
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        EC 3.2.1.18
       </registrynumber>
       <nameofsubstance ui="D009439">
        Neuraminidase
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        O3J8G9O825
       </registrynumber>
       <nameofsubstance ui="D019438">
        Ritonavir
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        OF5P57N2ZX
       </registrynumber>
       <nameofsubstance ui="D000409">
        Alanine
       </nameofsubstance>
      </chemical>
     </chemicallist>
     <supplmeshlist>
      <supplmeshname type="Disease" ui="C000657245">
       COVID-19
      </supplmeshname>
      <supplmeshname type="Protocol" ui="C000705127">
       COVID-19 drug treatment
      </supplmeshname>
      <supplmeshname type="Organism" ui="C000656484">
       severe acute respiratory syndrome coronavirus 2
      </supplmeshname>
     </supplmeshlist>
     <citationsubset>
      IM
     </citationsubset>
     <meshheadinglist>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000409">
        Alanine
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000031">
        analogs &amp; derivatives
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000998">
        Antiviral Agents
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="Y" ui="D000073640">
        Betacoronavirus
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D018352">
        Coronavirus Infections
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000188">
        drug therapy
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D004338">
        Drug Combinations
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D055808">
        Drug Discovery
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006801">
        Humans
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D061466">
        Lopinavir
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D009439">
        Neuraminidase
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000037">
        antagonists &amp; inhibitors
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D009705">
        Nucleosides
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D011024">
        Pneumonia, Viral
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000188">
        drug therapy
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D012265">
        Ribonucleotides
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D019438">
        Ritonavir
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
     </meshheadinglist>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       2019-nCoV
      </keyword>
      <keyword majortopicyn="N">
       Coronaviruses
      </keyword>
      <keyword majortopicyn="N">
       pneumonia
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        1
       </month>
       <day>
        31
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        19
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        1
       </month>
       <day>
        31
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       31996494
      </articleid>
      <articleid idtype="doi">
       10.5582/bst.2020.01020
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32147516
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       09
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1872-7913
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Mar
         </month>
         <day>
          06
         </day>
        </pubdate>
       </journalissue>
       <title>
        International journal of antimicrobial agents
       </title>
       <isoabbreviation>
        Int. J. Antimicrob. Agents
       </isoabbreviation>
      </journal>
      <articletitle>
       Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
      </articletitle>
      <pagination>
       <medlinepgn>
        105933
       </medlinepgn>
      </pagination>
      <elocationid eidtype="pii" validyn="Y">
       S0924-8579(20)30083-2
      </elocationid>
      <elocationid eidtype="doi" validyn="Y">
       10.1016/j.ijantimicag.2020.105933
      </elocationid>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Ko
        </lastname>
        <forename>
         Wen-Chien
        </forename>
        <initials>
         WC
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Center for Infection Control and Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Rolain
        </lastname>
        <forename>
         Jean-Marc
        </forename>
        <initials>
         JM
        </initials>
        <affiliationinfo>
         <affiliation>
          Aix-Marseille Université, Institut de Recherche pour le Développement (IRD), Assistance 7 Publique-Hôpitaux de Marseille (AP-HM), MEPHI, 27 boulevard Jean Moulin, 13005 8 Marseille, France; IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005 Marseille, France.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Lee
        </lastname>
        <forename>
         Nan-Yao
        </forename>
        <initials>
         NY
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Center for Infection Control and Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Chen
        </lastname>
        <forename>
         Po-Lin
        </forename>
        <initials>
         PL
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan; Center for Infection Control and Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Huang
        </lastname>
        <forename>
         Ching-Tai
        </forename>
        <initials>
         CT
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Infectious Diseases, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Lee
        </lastname>
        <forename>
         Ping-Ing
        </forename>
        <initials>
         PI
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Pediatrics, National Taiwan University Children's Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Hsueh
        </lastname>
        <forename>
         Po-Ren
        </forename>
        <initials>
         PR
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: hsporen@ntu.edu.tw.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016421">
        Editorial
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        06
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       Netherlands
      </country>
      <medlineta>
       Int J Antimicrob Agents
      </medlineta>
      <nlmuniqueid>
       9111860
      </nlmuniqueid>
      <issnlinking>
       0924-8579
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       Betacoronavirus
      </keyword>
      <keyword majortopicyn="N">
       COVID-19
      </keyword>
      <keyword majortopicyn="N">
       Coronavirus disease 2019
      </keyword>
      <keyword majortopicyn="N">
       Remdesivir
      </keyword>
      <keyword majortopicyn="N">
       SARS-CoV-2
      </keyword>
      <keyword majortopicyn="N">
       Wuhan pneumonia
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2020
       </year>
       <month>
        02
       </month>
       <day>
        16
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="revised">
       <year>
        2020
       </year>
       <month>
        02
       </month>
       <day>
        28
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        10
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        10
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        10
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32147516
      </articleid>
      <articleid idtype="pii">
       S0924-8579(20)30083-2
      </articleid>
      <articleid idtype="doi">
       10.1016/j.ijantimicag.2020.105933
      </articleid>
      <articleid idtype="pmc">
       PMC7135364
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2020 Feb 20;382(8):727-733
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31978945
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Sci Rep. 2017 Mar 06;7:43395
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28262699
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Med Chem. 2017 Mar 9;60(5):1648-1661
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28124907
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2019 Dec 12;381(24):2293-2303
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31774950
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2020 Feb 15;395(10223):497-506
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31986264
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2020 Feb 15;395(10223):507-513
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32007143
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Feline Med Surg. 2019 Apr;21(4):271-281
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30755068
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2020 Feb 15;395(10223):514-523
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31986261
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nature. 2016 Mar 17;531(7594):381-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26934220
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Chembiochem. 2020 Mar 2;21(5):730-738
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32022370
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Med Virol. 2020 Apr;92(4):418-423
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31967327
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="MEDLINE">
     <pmid version="1">
      31924756
     </pmid>
     <datecompleted>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       02
      </day>
     </datecompleted>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       07
      </day>
     </daterevised>
     <article pubmodel="Electronic">
      <journal>
       <issn issntype="Electronic">
        2041-1723
       </issn>
       <journalissue citedmedium="Internet">
        <volume>
         11
        </volume>
        <issue>
         1
        </issue>
        <pubdate>
         <year>
          2020
         </year>
         <month>
          01
         </month>
         <day>
          10
         </day>
        </pubdate>
       </journalissue>
       <title>
        Nature communications
       </title>
       <isoabbreviation>
        Nat Commun
       </isoabbreviation>
      </journal>
      <articletitle>
       Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.
      </articletitle>
      <pagination>
       <medlinepgn>
        222
       </medlinepgn>
      </pagination>
      <elocationid eidtype="doi" validyn="Y">
       10.1038/s41467-019-13940-6
      </elocationid>
      <abstract>
       <abstracttext>
        Middle East respiratory syndrome coronavirus (MERS-CoV) is the causative agent of a severe respiratory disease associated with more than 2468 human infections and over 851 deaths in 27 countries since 2012. There are no approved treatments for MERS-CoV infection although a combination of lopinavir, ritonavir and interferon beta (LPV/RTV-IFNb) is currently being evaluated in humans in the Kingdom of Saudi Arabia. Here, we show that remdesivir (RDV) and IFNb have superior antiviral activity to LPV and RTV in vitro. In mice, both prophylactic and therapeutic RDV improve pulmonary function and reduce lung viral loads and severe lung pathology. In contrast, prophylactic LPV/RTV-IFNb slightly reduces viral loads without impacting other disease parameters. Therapeutic LPV/RTV-IFNb improves pulmonary function but does not reduce virus replication or severe lung pathology. Thus, we provide in vivo evidence of the potential for RDV to treat MERS-CoV infections.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Sheahan
        </lastname>
        <forename>
         Timothy P
        </forename>
        <initials>
         TP
        </initials>
        <identifier source="ORCID">
         0000-0001-9181-2183
        </identifier>
        <affiliationinfo>
         <affiliation>
          Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. sheahan@email.unc.edu.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Sims
        </lastname>
        <forename>
         Amy C
        </forename>
        <initials>
         AC
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Leist
        </lastname>
        <forename>
         Sarah R
        </forename>
        <initials>
         SR
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Schäfer
        </lastname>
        <forename>
         Alexandra
        </forename>
        <initials>
         A
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Won
        </lastname>
        <forename>
         John
        </forename>
        <initials>
         J
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Brown
        </lastname>
        <forename>
         Ariane J
        </forename>
        <initials>
         AJ
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Montgomery
        </lastname>
        <forename>
         Stephanie A
        </forename>
        <initials>
         SA
        </initials>
        <identifier source="ORCID">
         0000-0001-8012-5302
        </identifier>
        <affiliationinfo>
         <affiliation>
          Department of Pathology &amp; Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Hogg
        </lastname>
        <forename>
         Alison
        </forename>
        <initials>
         A
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Inc, Foster City, CA, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Babusis
        </lastname>
        <forename>
         Darius
        </forename>
        <initials>
         D
        </initials>
        <identifier source="ORCID">
         0000-0001-5599-1671
        </identifier>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Inc, Foster City, CA, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Clarke
        </lastname>
        <forename>
         Michael O
        </forename>
        <initials>
         MO
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Inc, Foster City, CA, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Spahn
        </lastname>
        <forename>
         Jamie E
        </forename>
        <initials>
         JE
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Inc, Foster City, CA, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Bauer
        </lastname>
        <forename>
         Laura
        </forename>
        <initials>
         L
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Inc, Foster City, CA, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Sellers
        </lastname>
        <forename>
         Scott
        </forename>
        <initials>
         S
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Inc, Foster City, CA, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Porter
        </lastname>
        <forename>
         Danielle
        </forename>
        <initials>
         D
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Inc, Foster City, CA, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Feng
        </lastname>
        <forename>
         Joy Y
        </forename>
        <initials>
         JY
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Inc, Foster City, CA, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Cihlar
        </lastname>
        <forename>
         Tomas
        </forename>
        <initials>
         T
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Inc, Foster City, CA, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Jordan
        </lastname>
        <forename>
         Robert
        </forename>
        <initials>
         R
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Inc, Foster City, CA, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Denison
        </lastname>
        <forename>
         Mark R
        </forename>
        <initials>
         MR
        </initials>
        <identifier source="ORCID">
         0000-0003-2655-0900
        </identifier>
        <affiliationinfo>
         <affiliation>
          Department of Pediatrics-Infectious Diseases, Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Baric
        </lastname>
        <forename>
         Ralph S
        </forename>
        <initials>
         RS
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. rbaric@email.unc.edu.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <grantlist completeyn="Y">
       <grant>
        <grantid>
         U54 CA156733
        </grantid>
        <acronym>
         CA
        </acronym>
        <agency>
         NCI NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
       <grant>
        <grantid>
         P30 ES010126
        </grantid>
        <acronym>
         ES
        </acronym>
        <agency>
         NIEHS NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
       <grant>
        <grantid>
         R01 AI108197
        </grantid>
        <acronym>
         AI
        </acronym>
        <agency>
         NIAID NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
       <grant>
        <grantid>
         P30 CA016086
        </grantid>
        <acronym>
         CA
        </acronym>
        <agency>
         NCI NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
       <grant>
        <grantid>
         R01 AI132178
        </grantid>
        <acronym>
         AI
        </acronym>
        <agency>
         NIAID NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
       <grant>
        <grantid>
         U19 AI109680
        </grantid>
        <acronym>
         AI
        </acronym>
        <agency>
         NIAID NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
      </grantlist>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
       <publicationtype ui="D052061">
        Research Support, N.I.H., Extramural
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        01
       </month>
       <day>
        10
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       England
      </country>
      <medlineta>
       Nat Commun
      </medlineta>
      <nlmuniqueid>
       101528555
      </nlmuniqueid>
      <issnlinking>
       2041-1723
      </issnlinking>
     </medlinejournalinfo>
     <chemicallist>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D000998">
        Antiviral Agents
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D004338">
        Drug Combinations
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="C558899">
        lopinavir-ritonavir drug combination
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        2494G1JF75
       </registrynumber>
       <nameofsubstance ui="D061466">
        Lopinavir
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        3QKI37EEHE
       </registrynumber>
       <nameofsubstance ui="C000606551">
        remdesivir
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        415SHH325A
       </registrynumber>
       <nameofsubstance ui="D000249">
        Adenosine Monophosphate
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        77238-31-4
       </registrynumber>
       <nameofsubstance ui="D016899">
        Interferon-beta
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        EC 3.1.1.1
       </registrynumber>
       <nameofsubstance ui="D043182">
        Carboxylesterase
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        EC 3.1.1.1
       </registrynumber>
       <nameofsubstance ui="C469486">
        Ces1c protein, mouse
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        O3J8G9O825
       </registrynumber>
       <nameofsubstance ui="D019438">
        Ritonavir
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        OF5P57N2ZX
       </registrynumber>
       <nameofsubstance ui="D000409">
        Alanine
       </nameofsubstance>
      </chemical>
     </chemicallist>
     <citationsubset>
      IM
     </citationsubset>
     <meshheadinglist>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000249">
        Adenosine Monophosphate
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000031">
        analogs &amp; derivatives
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000409">
        Alanine
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000031">
        analogs &amp; derivatives
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000818">
        Animals
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000998">
        Antiviral Agents
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D043182">
        Carboxylesterase
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000235">
        genetics
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D018352">
        Coronavirus Infections
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000188">
        drug therapy
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000473">
        pathology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D004338">
        Drug Combinations
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000076722">
        Drug Development
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D005260">
        Female
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006801">
        Humans
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D016899">
        Interferon-beta
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D061466">
        Lopinavir
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D055370">
        Lung Injury
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000473">
        pathology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D008297">
        Male
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D051379">
        Mice
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D018345">
        Mice, Knockout
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D065207">
        Middle East Respiratory Syndrome Coronavirus
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000187">
        drug effects
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D019438">
        Ritonavir
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D019562">
        Viral Load
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D014779">
        Virus Replication
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000187">
        drug effects
       </qualifiername>
      </meshheading>
     </meshheadinglist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2019
       </year>
       <month>
        01
       </month>
       <day>
        03
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        2019
       </year>
       <month>
        12
       </month>
       <day>
        07
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        1
       </month>
       <day>
        12
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        1
       </month>
       <day>
        12
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        3
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      epublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       31924756
      </articleid>
      <articleid idtype="doi">
       10.1038/s41467-019-13940-6
      </articleid>
      <articleid idtype="pii">
       10.1038/s41467-019-13940-6
      </articleid>
      <articleid idtype="pmc">
       PMC6954302
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        Int J Antimicrob Agents. 2014 Dec;44(6):528-32
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25288266
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Am J Respir Cell Mol Biol. 2011 May;44(5):725-38
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21531958
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Am J Respir Cell Mol Biol. 2017 Feb;56(2):202-212
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27632156
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Infect Chemother. 2016 Jun;48(2):118-26
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27433382
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Infect Dis. 2016 Mar 1;213(5):712-22
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26486634
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        PLoS One. 2011;6(6):e21207
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21701593
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        mBio. 2018 Mar 6;9(2):
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29511076
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nat Microbiol. 2016 Nov 28;2:16226
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27892925
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16157-62
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24043791
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Rev Med Virol. 2018 May;28(3):e1977
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29664167
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Antimicrob Agents Chemother. 2014 Aug;58(8):4875-84
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24841269
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet Infect Dis. 2015 Jun;15(6):629
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26008827
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Br J Clin Pharmacol. 2008 Feb;65(2):158-62
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18070219
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Toxicol Pathol. 2015 Dec;43(8):1074-92
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26296628
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Virology. 2018 Apr;517:98-107
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29277291
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Infect Dis. 2015 Dec 15;212(12):1904-13
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26198719
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Sci Transl Med. 2017 Jun 28;9(396):
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28659436
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Virology. 2006 Jul 20;351(1):180-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16647731
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Virology. 2015 Nov;485:422-30
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26342468
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nat Rev Drug Discov. 2016 May;15(5):327-47
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26868298
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Antiviral Res. 2019 Sep;169:104541
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31233808
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Int J Mol Sci. 2018 Dec 12;19(12):null
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30545052
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Trials. 2018 Jan 30;19(1):81
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29382391
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nat Med. 2013 Oct;19(10):1313-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24013700
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Elife. 2018 Jan 16;7:
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29336306
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        HIV Med. 2011 Mar;12(3):166-73
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         20726906
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Viral Hepat. 2011 May;18(5):338-48
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         20456634
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Sci Rep. 2017 Mar 06;7:43395
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28262699
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nature. 2013 Nov 28;503(7477):535-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24172901
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Gen Virol. 2014 Mar;95(Pt 3):571-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24323636
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2016 Sep 3;388(10048):994-1001
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27402381
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Immunity. 2017 May 16;46(5):875-890.e6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28514692
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Viruses. 2019 Apr 04;11(4):
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30987343
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Basic Clin Pharm. 2016 Mar;7(2):27-31
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27057123
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        PLoS One. 2015 Jun 26;10(6):e0131451
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26115403
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Infect Dis. 2015 Dec 15;212(12):1894-903
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26164863
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        PLoS Pathog. 2014 Aug 21;10(8):e1004250
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25144235
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        PLoS Pathog. 2018 Feb 9;14(2):e1006889
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29425244
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nature. 2016 Mar 17;531(7594):381-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26934220
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4970-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24599590
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Infect. 2013 Dec;67(6):606-16
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24096239
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        EMBO Mol Med. 2016 Sep 01;8(9):1099-112
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27520969
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nat Rev Microbiol. 2016 Aug;14(8):523-34
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27344959
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Methods. 2001 Dec;25(4):402-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         11846609
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        N Engl J Med. 2016 Sep 29;375(13):1303-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27682053
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Antivir Ther. 2016;21(5):455-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26492219
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        PLoS Pathog. 2018 Jan 2;14(1):e1006810
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29293660
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Antiviral Res. 2018 Aug;156:64-71
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29885377
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Proc R Soc Lond B Biol Sci. 1957 Sep 12;147(927):258-67
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         13465720
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="MEDLINE">
     <pmid version="1">
      28659436
     </pmid>
     <datecompleted>
      <year>
       2018
      </year>
      <month>
       03
      </month>
      <day>
       30
      </day>
     </datecompleted>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       03
      </month>
      <day>
       16
      </day>
     </daterevised>
     <article pubmodel="Print">
      <journal>
       <issn issntype="Electronic">
        1946-6242
       </issn>
       <journalissue citedmedium="Internet">
        <volume>
         9
        </volume>
        <issue>
         396
        </issue>
        <pubdate>
         <year>
          2017
         </year>
         <month>
          06
         </month>
         <day>
          28
         </day>
        </pubdate>
       </journalissue>
       <title>
        Science translational medicine
       </title>
       <isoabbreviation>
        Sci Transl Med
       </isoabbreviation>
      </journal>
      <articletitle>
       Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.
      </articletitle>
      <elocationid eidtype="pii" validyn="Y">
       eaal3653
      </elocationid>
      <elocationid eidtype="doi" validyn="Y">
       10.1126/scitranslmed.aal3653
      </elocationid>
      <abstract>
       <abstracttext>
        Emerging viral infections are difficult to control because heterogeneous members periodically cycle in and out of humans and zoonotic hosts, complicating the development of specific antiviral therapies and vaccines. Coronaviruses (CoVs) have a proclivity to spread rapidly into new host species causing severe disease. Severe acute respiratory syndrome CoV (SARS-CoV) and Middle East respiratory syndrome CoV (MERS-CoV) successively emerged, causing severe epidemic respiratory disease in immunologically naïve human populations throughout the globe. Broad-spectrum therapies capable of inhibiting CoV infections would address an immediate unmet medical need and could be invaluable in the treatment of emerging and endemic CoV infections. We show that a nucleotide prodrug, GS-5734, currently in clinical development for treatment of Ebola virus disease, can inhibit SARS-CoV and MERS-CoV replication in multiple in vitro systems, including primary human airway epithelial cell cultures with submicromolar IC
        <sub>
         50
        </sub>
        values. GS-5734 was also effective against bat CoVs, prepandemic bat CoVs, and circulating contemporary human CoV in primary human lung cells, thus demonstrating broad-spectrum anti-CoV activity. In a mouse model of SARS-CoV pathogenesis, prophylactic and early therapeutic administration of GS-5734 significantly reduced lung viral load and improved clinical signs of disease as well as respiratory function. These data provide substantive evidence that GS-5734 may prove effective against endemic MERS-CoV in the Middle East, circulating human CoV, and, possibly most importantly, emerging CoV of the future.
       </abstracttext>
       <copyrightinformation>
        Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Sheahan
        </lastname>
        <forename>
         Timothy P
        </forename>
        <initials>
         TP
        </initials>
        <identifier source="ORCID">
         0000-0001-9181-2183
        </identifier>
        <affiliationinfo>
         <affiliation>
          Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Sims
        </lastname>
        <forename>
         Amy C
        </forename>
        <initials>
         AC
        </initials>
        <identifier source="ORCID">
         0000-0003-0178-4225
        </identifier>
        <affiliationinfo>
         <affiliation>
          Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Graham
        </lastname>
        <forename>
         Rachel L
        </forename>
        <initials>
         RL
        </initials>
        <identifier source="ORCID">
         0000-0002-3143-6515
        </identifier>
        <affiliationinfo>
         <affiliation>
          Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Menachery
        </lastname>
        <forename>
         Vineet D
        </forename>
        <initials>
         VD
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Gralinski
        </lastname>
        <forename>
         Lisa E
        </forename>
        <initials>
         LE
        </initials>
        <identifier source="ORCID">
         0000-0003-1374-8002
        </identifier>
        <affiliationinfo>
         <affiliation>
          Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Case
        </lastname>
        <forename>
         James B
        </forename>
        <initials>
         JB
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Leist
        </lastname>
        <forename>
         Sarah R
        </forename>
        <initials>
         SR
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Pyrc
        </lastname>
        <forename>
         Krzysztof
        </forename>
        <initials>
         K
        </initials>
        <identifier source="ORCID">
         0000-0002-3867-7688
        </identifier>
        <affiliationinfo>
         <affiliation>
          Department of Microbiology, Faculty of Biochemistry, Biophysics, and Biotechnology, Jagiellonian University, Krakow, Poland.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Feng
        </lastname>
        <forename>
         Joy Y
        </forename>
        <initials>
         JY
        </initials>
        <identifier source="ORCID">
         0000-0003-4837-1911
        </identifier>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences Inc., Foster City, CA 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Trantcheva
        </lastname>
        <forename>
         Iva
        </forename>
        <initials>
         I
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences Inc., Foster City, CA 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Bannister
        </lastname>
        <forename>
         Roy
        </forename>
        <initials>
         R
        </initials>
        <identifier source="ORCID">
         0000-0002-6311-1440
        </identifier>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences Inc., Foster City, CA 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Park
        </lastname>
        <forename>
         Yeojin
        </forename>
        <initials>
         Y
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences Inc., Foster City, CA 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Babusis
        </lastname>
        <forename>
         Darius
        </forename>
        <initials>
         D
        </initials>
        <identifier source="ORCID">
         0000-0001-5599-1671
        </identifier>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences Inc., Foster City, CA 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Clarke
        </lastname>
        <forename>
         Michael O
        </forename>
        <initials>
         MO
        </initials>
        <identifier source="ORCID">
         0000-0002-7266-1364
        </identifier>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences Inc., Foster City, CA 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Mackman
        </lastname>
        <forename>
         Richard L
        </forename>
        <initials>
         RL
        </initials>
        <identifier source="ORCID">
         0000-0001-8861-7205
        </identifier>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences Inc., Foster City, CA 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Spahn
        </lastname>
        <forename>
         Jamie E
        </forename>
        <initials>
         JE
        </initials>
        <identifier source="ORCID">
         0000-0003-2110-5824
        </identifier>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences Inc., Foster City, CA 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Palmiotti
        </lastname>
        <forename>
         Christopher A
        </forename>
        <initials>
         CA
        </initials>
        <identifier source="ORCID">
         0000-0001-9367-2487
        </identifier>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences Inc., Foster City, CA 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Siegel
        </lastname>
        <forename>
         Dustin
        </forename>
        <initials>
         D
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences Inc., Foster City, CA 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Ray
        </lastname>
        <forename>
         Adrian S
        </forename>
        <initials>
         AS
        </initials>
        <identifier source="ORCID">
         0000-0002-3508-3008
        </identifier>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences Inc., Foster City, CA 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Cihlar
        </lastname>
        <forename>
         Tomas
        </forename>
        <initials>
         T
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences Inc., Foster City, CA 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Jordan
        </lastname>
        <forename>
         Robert
        </forename>
        <initials>
         R
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences Inc., Foster City, CA 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Denison
        </lastname>
        <forename>
         Mark R
        </forename>
        <initials>
         MR
        </initials>
        <affiliationinfo>
         <affiliation>
          Division of Infectious Diseases, Department of Pediatrics and Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA. mark.denison@vanderbilt.edu rbaric@email.unc.edu.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Baric
        </lastname>
        <forename>
         Ralph S
        </forename>
        <initials>
         RS
        </initials>
        <identifier source="ORCID">
         0000-0001-6827-8701
        </identifier>
        <affiliationinfo>
         <affiliation>
          Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. mark.denison@vanderbilt.edu rbaric@email.unc.edu.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <grantlist completeyn="Y">
       <grant>
        <grantid>
         U19 AI109761
        </grantid>
        <acronym>
         AI
        </acronym>
        <agency>
         NIAID NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
       <grant>
        <grantid>
         R01 AI108197
        </grantid>
        <acronym>
         AI
        </acronym>
        <agency>
         NIAID NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
       <grant>
        <grantid>
         R01 AI132178
        </grantid>
        <acronym>
         AI
        </acronym>
        <agency>
         NIAID NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
       <grant>
        <grantid>
         P30 DK065988
        </grantid>
        <acronym>
         DK
        </acronym>
        <agency>
         NIDDK NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
       <grant>
        <grantid>
         U19 AI109680
        </grantid>
        <acronym>
         AI
        </acronym>
        <agency>
         NIAID NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
      </grantlist>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
     </article>
     <medlinejournalinfo>
      <country>
       United States
      </country>
      <medlineta>
       Sci Transl Med
      </medlineta>
      <nlmuniqueid>
       101505086
      </nlmuniqueid>
      <issnlinking>
       1946-6234
      </issnlinking>
     </medlinejournalinfo>
     <chemicallist>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D000998">
        Antiviral Agents
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D012265">
        Ribonucleotides
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        3QKI37EEHE
       </registrynumber>
       <nameofsubstance ui="C000606551">
        remdesivir
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        OF5P57N2ZX
       </registrynumber>
       <nameofsubstance ui="D000409">
        Alanine
       </nameofsubstance>
      </chemical>
     </chemicallist>
     <citationsubset>
      IM
     </citationsubset>
     <meshheadinglist>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000409">
        Alanine
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000031">
        analogs &amp; derivatives
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000378">
        metabolism
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000493">
        pharmacokinetics
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000494">
        pharmacology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000633">
        toxicity
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000818">
        Animals
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000998">
        Antiviral Agents
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000378">
        metabolism
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000493">
        pharmacokinetics
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000494">
        pharmacology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000633">
        toxicity
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D002144">
        Callithrix
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D002460">
        Cell Line
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D017934">
        Coronavirus
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000187">
        drug effects
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="Y" ui="D058872">
        Epidemics
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D004847">
        Epithelial Cells
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000821">
        virology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006801">
        Humans
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D008168">
        Lung
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000473">
        pathology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D051379">
        Mice
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D012265">
        Ribonucleotides
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000378">
        metabolism
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000493">
        pharmacokinetics
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000494">
        pharmacology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000633">
        toxicity
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D014779">
        Virus Replication
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000187">
        drug effects
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D015047">
        Zoonoses
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000453">
        epidemiology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000517">
        prevention &amp; control
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000821">
        virology
       </qualifiername>
      </meshheading>
     </meshheadinglist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2016
       </year>
       <month>
        11
       </month>
       <day>
        08
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        2017
       </year>
       <month>
        05
       </month>
       <day>
        17
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2017
       </year>
       <month>
        6
       </month>
       <day>
        30
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2017
       </year>
       <month>
        7
       </month>
       <day>
        1
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2018
       </year>
       <month>
        3
       </month>
       <day>
        31
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       28659436
      </articleid>
      <articleid idtype="pii">
       9/396/eaal3653
      </articleid>
      <articleid idtype="doi">
       10.1126/scitranslmed.aal3653
      </articleid>
      <articleid idtype="pmc">
       PMC5567817
      </articleid>
      <articleid idtype="mid">
       NIHMS895143
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        PLoS One. 2015 Jun 26;10(6):e0131451
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26115403
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        PLoS Pathog. 2010 May 06;6(5):e1000896
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         20463816
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3048-53
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26976607
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nat Microbiol. 2016 Nov 28;2:16226
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27892925
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Biochem Pharmacol. 2005 Nov 25;70(11):1673-84
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16213467
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Lancet. 2003 May 24;361(9371):1767-72
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         12781535
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Clin Infect Dis. 2011 Feb 15;52(4):457-65
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         21220768
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Emerg Infect Dis. 2016 Jun;22(6):1086-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27071076
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        N Engl J Med. 2016 Sep 29;375(13):1303-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27682053
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        MBio. 2013 Aug 06;4(4):null
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23919993
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nat Rev Drug Discov. 2016 May;15(5):327-47
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26868298
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nat Rev Microbiol. 2016 Aug;14 (8):523-34
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27344959
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Virol. 2005 Dec;79(24):15511-24
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16306622
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Gen Virol. 2014 Mar;95(Pt 3):571-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24323636
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19944-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19036930
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16157-62
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24043791
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Infect Dis. 2015 Dec 15;212(12):1904-13
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26198719
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Antiviral Res. 2006 Aug;71(1):53-63
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16621037
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Clin Microbiol Rev. 2015 Apr;28(2):465-522
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25810418
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nat Med. 2015 Dec;21(12):1508-13
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26552008
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16119-24
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18852458
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Bioorg Med Chem Lett. 2012 Apr 15;22(8):2705-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         22446091
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Biochem Biophys Res Commun. 2005 Jan 28;326(4):905-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15607755
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Virol. 2013 Apr;87(7):3885-902
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23365422
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Virol. 2008 Dec;82(23):11948-57
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18818320
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Lancet. 2016 Jul 30;388(10043):498-503
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         27209148
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Virol. 2009 May;83(9):4538-47
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19244331
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        MBio. 2014 Mar 25;5(2):e00047-14
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24667706
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Biochem Biophys Res Commun. 2004 Jun 4;318(3):719-25
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15144898
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Sci Rep. 2013;3:1686
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23594967
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Infect. 2013 Dec;67(6):606-16
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24096239
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Infect Dis. 2013 May 1;207(9):1442-50
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         22807519
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Lancet Infect Dis. 2015 May;15(5):559-64
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25863564
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nature. 2016 Mar 17;531(7594):381-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26934220
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32173241
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       09
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1995-9133
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Mar
         </month>
         <day>
          04
         </day>
        </pubdate>
       </journalissue>
       <title>
        Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
       </title>
       <isoabbreviation>
        J Microbiol Immunol Infect
       </isoabbreviation>
      </journal>
      <articletitle>
       Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.
      </articletitle>
      <elocationid eidtype="pii" validyn="Y">
       S1684-1182(20)30040-2
      </elocationid>
      <elocationid eidtype="doi" validyn="Y">
       10.1016/j.jmii.2020.02.012
      </elocationid>
      <abstract>
       <abstracttext>
        Since the emergence of coronavirus disease 2019 (COVID-19) (formerly known as the 2019 novel coronavirus [2019-nCoV]) in Wuhan, China in December 2019, which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), more than 75,000 cases have been reported in 32 countries/regions, resulting in more than 2000 deaths worldwide. Despite the fact that most COVID-19 cases and mortalities were reported in China, the WHO has declared this outbreak as the sixth public health emergency of international concern. The COVID-19 can present as an asymptomatic carrier state, acute respiratory disease, and pneumonia. Adults represent the population with the highest infection rate; however, neonates, children, and elderly patients can also be infected by SARS-CoV-2. In addition, nosocomial infection of hospitalized patients and healthcare workers, and viral transmission from asymptomatic carriers are possible. The most common finding on chest imaging among patients with pneumonia was ground-glass opacity with bilateral involvement. Severe cases are more likely to be older patients with underlying comorbidities compared to mild cases. Indeed, age and disease severity may be correlated with the outcomes of COVID-19. To date, effective treatment is lacking; however, clinical trials investigating the efficacy of several agents, including remdesivir and chloroquine, are underway in China. Currently, effective infection control intervention is the only way to prevent the spread of SARS-CoV-2.
       </abstracttext>
       <copyrightinformation>
        Copyright © 2020. Published by Elsevier B.V.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Lai
        </lastname>
        <forename>
         Chih-Cheng
        </forename>
        <initials>
         CC
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Internal Medicine, Kaohsiung Veterans General Hospital, Tainan Branch, Tainan, Taiwan.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Liu
        </lastname>
        <forename>
         Yen Hung
        </forename>
        <initials>
         YH
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Internal Medicine, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wang
        </lastname>
        <forename>
         Cheng-Yi
        </forename>
        <initials>
         CY
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Internal Medicine, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wang
        </lastname>
        <forename>
         Ya-Hui
        </forename>
        <initials>
         YH
        </initials>
        <affiliationinfo>
         <affiliation>
          Medical Research Center, Cardinal Tien Hospital and School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Hsueh
        </lastname>
        <forename>
         Shun-Chung
        </forename>
        <initials>
         SC
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Yen
        </lastname>
        <forename>
         Muh-Yen
        </forename>
        <initials>
         MY
        </initials>
        <affiliationinfo>
         <affiliation>
          Section of Infectious Diseases, Taipei City Hospital, Taipei, Taiwan; Department of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Ko
        </lastname>
        <forename>
         Wen-Chien
        </forename>
        <initials>
         WC
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Hsueh
        </lastname>
        <forename>
         Po-Ren
        </forename>
        <initials>
         PR
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Laboratory Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. Electronic address: hsporen@ntu.edu.tw.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
       <publicationtype ui="D016454">
        Review
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        03
       </month>
       <day>
        04
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       England
      </country>
      <medlineta>
       J Microbiol Immunol Infect
      </medlineta>
      <nlmuniqueid>
       100956211
      </nlmuniqueid>
      <issnlinking>
       1684-1182
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       2019-nCoV
      </keyword>
      <keyword majortopicyn="N">
       Acute respiratory disease
      </keyword>
      <keyword majortopicyn="N">
       Asymptomatic carrier
      </keyword>
      <keyword majortopicyn="N">
       COVID-19
      </keyword>
      <keyword majortopicyn="N">
       Coronavirus
      </keyword>
      <keyword majortopicyn="N">
       SARS-CoV-2
      </keyword>
      <keyword majortopicyn="N">
       Wuhan pneumonia
      </keyword>
     </keywordlist>
     <coistatement>
      Declaration of competing interest The author declares no conflict of interests.
     </coistatement>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2020
       </year>
       <month>
        02
       </month>
       <day>
        25
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        2020
       </year>
       <month>
        02
       </month>
       <day>
        25
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        3
       </month>
       <day>
        17
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32173241
      </articleid>
      <articleid idtype="pii">
       S1684-1182(20)30040-2
      </articleid>
      <articleid idtype="doi">
       10.1016/j.jmii.2020.02.012
      </articleid>
      <articleid idtype="pmc">
       PMC7128959
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        Clin Infect Dis. 2015 Dec 1;61(11):1761-2
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26240205
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        MMWR Morb Mortal Wkly Rep. 2020 Feb 07;69(5):140-146
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32027631
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Clin Infect Dis. 2004 Oct 15;39(8):1247-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15486852
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Epidemiol Health. 2020;42:e2020006
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32023775
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Clin Med. 2020 Feb 11;9(2):
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32054045
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Biol Chem. 2016 Apr 22;291(17):9218-32
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26953343
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Eur J Med Chem. 2018 Sep 5;157:1017-1030
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         30170320
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2020 Feb 15;395(10223):497-506
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31986264
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2020 Feb 15;395(10223):473-475
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32043983
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Antiviral Res. 2006 Oct;72(1):20-33
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         16675038
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Med Virol. 2020 Apr;92(4):424-432
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31981224
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Am J Respir Crit Care Med. 2018 Mar 15;197(6):757-767
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29161116
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Clin Virol. 2004 Dec;31(4):304-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15494274
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2020 Feb 15;395(10223):514-523
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31986261
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Zhonghua Nei Ke Za Zhi. 2004 Mar;43(3):179-82
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15059370
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Front Microbiol. 2019 Dec 03;10:2752
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31849894
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 20;43(0):E019
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32075365
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Lancet. 2020 Feb 15;395(10223):507-513
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32007143
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32282022
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       13
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1538-3598
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          13
         </day>
        </pubdate>
       </journalissue>
       <title>
        JAMA
       </title>
       <isoabbreviation>
        JAMA
       </isoabbreviation>
      </journal>
      <articletitle>
       Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
      </articletitle>
      <elocationid eidtype="doi" validyn="Y">
       10.1001/jama.2020.6019
      </elocationid>
      <abstract>
       <abstracttext label="Importance" nlmcategory="UNASSIGNED">
        The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented challenge to identify effective drugs for prevention and treatment. Given the rapid pace of scientific discovery and clinical data generated by the large number of people rapidly infected by SARS-CoV-2, clinicians need accurate evidence regarding effective medical treatments for this infection.
       </abstracttext>
       <abstracttext label="Observations" nlmcategory="UNASSIGNED">
        No proven effective therapies for this virus currently exist. The rapidly expanding knowledge regarding SARS-CoV-2 virology provides a significant number of potential drug targets. The most promising therapy is remdesivir. Remdesivir has potent in vitro activity against SARS-CoV-2, but it is not US Food and Drug Administration approved and currently is being tested in ongoing randomized trials. Oseltamivir has not been shown to have efficacy, and corticosteroids are currently not recommended. Current clinical evidence does not support stopping angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in patients with COVID-19.
       </abstracttext>
       <abstracttext label="Conclusions and Relevance" nlmcategory="UNASSIGNED">
        The COVID-19 pandemic represents the greatest global public health crisis of this generation and, potentially, since the pandemic influenza outbreak of 1918. The speed and volume of clinical trials launched to investigate potential therapies for COVID-19 highlight both the need and capability to produce high-quality evidence even in the middle of a pandemic. No therapies have been shown effective to date.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Sanders
        </lastname>
        <forename>
         James M
        </forename>
        <initials>
         JM
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Pharmacy, University of Texas Southwestern Medical Center, Dallas.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Division of Infectious Diseases and Geographic Medicine, Department of Medicine, University of Texas Southwestern Medical Center, Dallas.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Monogue
        </lastname>
        <forename>
         Marguerite L
        </forename>
        <initials>
         ML
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Pharmacy, University of Texas Southwestern Medical Center, Dallas.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          Division of Infectious Diseases and Geographic Medicine, Department of Medicine, University of Texas Southwestern Medical Center, Dallas.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Jodlowski
        </lastname>
        <forename>
         Tomasz Z
        </forename>
        <initials>
         TZ
        </initials>
        <affiliationinfo>
         <affiliation>
          Pharmacy Service, VA North Texas Health Care System, Dallas.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Cutrell
        </lastname>
        <forename>
         James B
        </forename>
        <initials>
         JB
        </initials>
        <affiliationinfo>
         <affiliation>
          Division of Infectious Diseases and Geographic Medicine, Department of Medicine, University of Texas Southwestern Medical Center, Dallas.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        13
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       United States
      </country>
      <medlineta>
       JAMA
      </medlineta>
      <nlmuniqueid>
       7501160
      </nlmuniqueid>
      <issnlinking>
       0098-7484
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      AIM
     </citationsubset>
     <citationsubset>
      IM
     </citationsubset>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        14
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        14
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        14
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32282022
      </articleid>
      <articleid idtype="pii">
       2764727
      </articleid>
      <articleid idtype="doi">
       10.1001/jama.2020.6019
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="MEDLINE">
     <pmid version="1">
      26934220
     </pmid>
     <datecompleted>
      <year>
       2016
      </year>
      <month>
       04
      </month>
      <day>
       12
      </day>
     </datecompleted>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       03
      </month>
      <day>
       16
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1476-4687
       </issn>
       <journalissue citedmedium="Internet">
        <volume>
         531
        </volume>
        <issue>
         7594
        </issue>
        <pubdate>
         <year>
          2016
         </year>
         <month>
          Mar
         </month>
         <day>
          17
         </day>
        </pubdate>
       </journalissue>
       <title>
        Nature
       </title>
       <isoabbreviation>
        Nature
       </isoabbreviation>
      </journal>
      <articletitle>
       Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.
      </articletitle>
      <pagination>
       <medlinepgn>
        381-5
       </medlinepgn>
      </pagination>
      <elocationid eidtype="doi" validyn="Y">
       10.1038/nature17180
      </elocationid>
      <abstract>
       <abstracttext>
        The most recent Ebola virus outbreak in West Africa, which was unprecedented in the number of cases and fatalities, geographic distribution, and number of nations affected, highlights the need for safe, effective, and readily available antiviral agents for treatment and prevention of acute Ebola virus (EBOV) disease (EVD) or sequelae. No antiviral therapeutics have yet received regulatory approval or demonstrated clinical efficacy. Here we report the discovery of a novel small molecule GS-5734, a monophosphoramidate prodrug of an adenosine analogue, with antiviral activity against EBOV. GS-5734 exhibits antiviral activity against multiple variants of EBOV and other filoviruses in cell-based assays. The pharmacologically active nucleoside triphosphate (NTP) is efficiently formed in multiple human cell types incubated with GS-5734 in vitro, and the NTP acts as an alternative substrate and RNA-chain terminator in primer-extension assays using a surrogate respiratory syncytial virus RNA polymerase. Intravenous administration of GS-5734 to nonhuman primates resulted in persistent NTP levels in peripheral blood mononuclear cells (half-life, 14 h) and distribution to sanctuary sites for viral replication including testes, eyes, and brain. In a rhesus monkey model of EVD, once-daily intravenous administration of 10 mg kg(-1) GS-5734 for 12 days resulted in profound suppression of EBOV replication and protected 100% of EBOV-infected animals against lethal disease, ameliorating clinical disease signs and pathophysiological markers, even when treatments were initiated three days after virus exposure when systemic viral RNA was detected in two out of six treated animals. These results show the first substantive post-exposure protection by a small-molecule antiviral compound against EBOV in nonhuman primates. The broad-spectrum antiviral activity of GS-5734 in vitro against other pathogenic RNA viruses, including filoviruses, arenaviruses, and coronaviruses, suggests the potential for wider medical use. GS-5734 is amenable to large-scale manufacturing, and clinical studies investigating the drug safety and pharmacokinetics are ongoing.
       </abstracttext>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Warren
        </lastname>
        <forename>
         Travis K
        </forename>
        <initials>
         TK
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Therapeutic Development Center, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Jordan
        </lastname>
        <forename>
         Robert
        </forename>
        <initials>
         R
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Lo
        </lastname>
        <forename>
         Michael K
        </forename>
        <initials>
         MK
        </initials>
        <affiliationinfo>
         <affiliation>
          Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Ray
        </lastname>
        <forename>
         Adrian S
        </forename>
        <initials>
         AS
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Mackman
        </lastname>
        <forename>
         Richard L
        </forename>
        <initials>
         RL
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Soloveva
        </lastname>
        <forename>
         Veronica
        </forename>
        <initials>
         V
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Therapeutic Development Center, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Siegel
        </lastname>
        <forename>
         Dustin
        </forename>
        <initials>
         D
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Perron
        </lastname>
        <forename>
         Michel
        </forename>
        <initials>
         M
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Bannister
        </lastname>
        <forename>
         Roy
        </forename>
        <initials>
         R
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Hui
        </lastname>
        <forename>
         Hon C
        </forename>
        <initials>
         HC
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Larson
        </lastname>
        <forename>
         Nate
        </forename>
        <initials>
         N
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Strickley
        </lastname>
        <forename>
         Robert
        </forename>
        <initials>
         R
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wells
        </lastname>
        <forename>
         Jay
        </forename>
        <initials>
         J
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Stuthman
        </lastname>
        <forename>
         Kelly S
        </forename>
        <initials>
         KS
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Van Tongeren
        </lastname>
        <forename>
         Sean A
        </forename>
        <initials>
         SA
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Garza
        </lastname>
        <forename>
         Nicole L
        </forename>
        <initials>
         NL
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Donnelly
        </lastname>
        <forename>
         Ginger
        </forename>
        <initials>
         G
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Shurtleff
        </lastname>
        <forename>
         Amy C
        </forename>
        <initials>
         AC
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Retterer
        </lastname>
        <forename>
         Cary J
        </forename>
        <initials>
         CJ
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Gharaibeh
        </lastname>
        <forename>
         Dima
        </forename>
        <initials>
         D
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Zamani
        </lastname>
        <forename>
         Rouzbeh
        </forename>
        <initials>
         R
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Kenny
        </lastname>
        <forename>
         Tara
        </forename>
        <initials>
         T
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Eaton
        </lastname>
        <forename>
         Brett P
        </forename>
        <initials>
         BP
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Grimes
        </lastname>
        <forename>
         Elizabeth
        </forename>
        <initials>
         E
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Welch
        </lastname>
        <forename>
         Lisa S
        </forename>
        <initials>
         LS
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Gomba
        </lastname>
        <forename>
         Laura
        </forename>
        <initials>
         L
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Therapeutic Development Center, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wilhelmsen
        </lastname>
        <forename>
         Catherine L
        </forename>
        <initials>
         CL
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Nichols
        </lastname>
        <forename>
         Donald K
        </forename>
        <initials>
         DK
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Nuss
        </lastname>
        <forename>
         Jonathan E
        </forename>
        <initials>
         JE
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Therapeutic Development Center, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Nagle
        </lastname>
        <forename>
         Elyse R
        </forename>
        <initials>
         ER
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Kugelman
        </lastname>
        <forename>
         Jeffrey R
        </forename>
        <initials>
         JR
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Palacios
        </lastname>
        <forename>
         Gustavo
        </forename>
        <initials>
         G
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Doerffler
        </lastname>
        <forename>
         Edward
        </forename>
        <initials>
         E
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Neville
        </lastname>
        <forename>
         Sean
        </forename>
        <initials>
         S
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Carra
        </lastname>
        <forename>
         Ernest
        </forename>
        <initials>
         E
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Clarke
        </lastname>
        <forename>
         Michael O
        </forename>
        <initials>
         MO
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Zhang
        </lastname>
        <forename>
         Lijun
        </forename>
        <initials>
         L
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Lew
        </lastname>
        <forename>
         Willard
        </forename>
        <initials>
         W
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Ross
        </lastname>
        <forename>
         Bruce
        </forename>
        <initials>
         B
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wang
        </lastname>
        <forename>
         Queenie
        </forename>
        <initials>
         Q
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Chun
        </lastname>
        <forename>
         Kwon
        </forename>
        <initials>
         K
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wolfe
        </lastname>
        <forename>
         Lydia
        </forename>
        <initials>
         L
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Babusis
        </lastname>
        <forename>
         Darius
        </forename>
        <initials>
         D
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Park
        </lastname>
        <forename>
         Yeojin
        </forename>
        <initials>
         Y
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Stray
        </lastname>
        <forename>
         Kirsten M
        </forename>
        <initials>
         KM
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Trancheva
        </lastname>
        <forename>
         Iva
        </forename>
        <initials>
         I
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Feng
        </lastname>
        <forename>
         Joy Y
        </forename>
        <initials>
         JY
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Barauskas
        </lastname>
        <forename>
         Ona
        </forename>
        <initials>
         O
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Xu
        </lastname>
        <forename>
         Yili
        </forename>
        <initials>
         Y
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Wong
        </lastname>
        <forename>
         Pamela
        </forename>
        <initials>
         P
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Braun
        </lastname>
        <forename>
         Molly R
        </forename>
        <initials>
         MR
        </initials>
        <affiliationinfo>
         <affiliation>
          Boston University School of Medicine, Boston, Massachusetts 02118, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Flint
        </lastname>
        <forename>
         Mike
        </forename>
        <initials>
         M
        </initials>
        <affiliationinfo>
         <affiliation>
          Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         McMullan
        </lastname>
        <forename>
         Laura K
        </forename>
        <initials>
         LK
        </initials>
        <affiliationinfo>
         <affiliation>
          Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Chen
        </lastname>
        <forename>
         Shan-Shan
        </forename>
        <initials>
         SS
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Fearns
        </lastname>
        <forename>
         Rachel
        </forename>
        <initials>
         R
        </initials>
        <affiliationinfo>
         <affiliation>
          Boston University School of Medicine, Boston, Massachusetts 02118, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Swaminathan
        </lastname>
        <forename>
         Swami
        </forename>
        <initials>
         S
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Mayers
        </lastname>
        <forename>
         Douglas L
        </forename>
        <initials>
         DL
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Spiropoulou
        </lastname>
        <forename>
         Christina F
        </forename>
        <initials>
         CF
        </initials>
        <affiliationinfo>
         <affiliation>
          Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Lee
        </lastname>
        <forename>
         William A
        </forename>
        <initials>
         WA
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Nichol
        </lastname>
        <forename>
         Stuart T
        </forename>
        <initials>
         ST
        </initials>
        <affiliationinfo>
         <affiliation>
          Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Cihlar
        </lastname>
        <forename>
         Tomas
        </forename>
        <initials>
         T
        </initials>
        <affiliationinfo>
         <affiliation>
          Gilead Sciences, Foster City, California 94404, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Bavari
        </lastname>
        <forename>
         Sina
        </forename>
        <initials>
         S
        </initials>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
        <affiliationinfo>
         <affiliation>
          United States Army Medical Research Institute of Infectious Diseases, Therapeutic Development Center, Frederick, Maryland 21702, USA.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <grantlist completeyn="Y">
       <grant>
        <grantid>
         R01 AI113321
        </grantid>
        <acronym>
         AI
        </acronym>
        <agency>
         NIAID NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
       <grant>
        <grantid>
         R01AI113321
        </grantid>
        <acronym>
         AI
        </acronym>
        <agency>
         NIAID NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
      </grantlist>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
       <publicationtype ui="D052061">
        Research Support, N.I.H., Extramural
       </publicationtype>
       <publicationtype ui="D013486">
        Research Support, U.S. Gov't, Non-P.H.S.
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2016
       </year>
       <month>
        03
       </month>
       <day>
        02
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       England
      </country>
      <medlineta>
       Nature
      </medlineta>
      <nlmuniqueid>
       0410462
      </nlmuniqueid>
      <issnlinking>
       0028-0836
      </issnlinking>
     </medlinejournalinfo>
     <chemicallist>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D000998">
        Antiviral Agents
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D011355">
        Prodrugs
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        0
       </registrynumber>
       <nameofsubstance ui="D012265">
        Ribonucleotides
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        3QKI37EEHE
       </registrynumber>
       <nameofsubstance ui="C000606551">
        remdesivir
       </nameofsubstance>
      </chemical>
      <chemical>
       <registrynumber>
        OF5P57N2ZX
       </registrynumber>
       <nameofsubstance ui="D000409">
        Alanine
       </nameofsubstance>
      </chemical>
     </chemicallist>
     <citationsubset>
      IM
     </citationsubset>
     <commentscorrectionslist>
      <commentscorrections reftype="ErratumIn">
       <refsource>
        ACS Chem Biol. 2016 May 20;11(5):1463
       </refsource>
       <pmid version="1">
        27152473
       </pmid>
      </commentscorrections>
     </commentscorrectionslist>
     <meshheadinglist>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000409">
        Alanine
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000031">
        analogs &amp; derivatives
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000493">
        pharmacokinetics
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000494">
        pharmacology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000595">
        Amino Acid Sequence
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000818">
        Animals
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D000998">
        Antiviral Agents
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000493">
        pharmacokinetics
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000494">
        pharmacology
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D045744">
        Cell Line, Tumor
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D029043">
        Ebolavirus
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000187">
        drug effects
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D005260">
        Female
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006367">
        HeLa Cells
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D019142">
        Hemorrhagic Fever, Ebola
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000188">
        drug therapy
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000517">
        prevention &amp; control
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D006801">
        Humans
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D008253">
        Macaca mulatta
       </descriptorname>
       <qualifiername majortopicyn="Y" ui="Q000821">
        virology
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D008297">
        Male
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D008969">
        Molecular Sequence Data
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D009928">
        Organ Specificity
       </descriptorname>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D011355">
        Prodrugs
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000493">
        pharmacokinetics
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000494">
        pharmacology
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
      <meshheading>
       <descriptorname majortopicyn="N" ui="D012265">
        Ribonucleotides
       </descriptorname>
       <qualifiername majortopicyn="N" ui="Q000493">
        pharmacokinetics
       </qualifiername>
       <qualifiername majortopicyn="N" ui="Q000494">
        pharmacology
       </qualifiername>
       <qualifiername majortopicyn="Y" ui="Q000627">
        therapeutic use
       </qualifiername>
      </meshheading>
     </meshheadinglist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="received">
       <year>
        2015
       </year>
       <month>
        10
       </month>
       <day>
        26
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="accepted">
       <year>
        2016
       </year>
       <month>
        01
       </month>
       <day>
        29
       </day>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2016
       </year>
       <month>
        3
       </month>
       <day>
        3
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2016
       </year>
       <month>
        3
       </month>
       <day>
        5
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2016
       </year>
       <month>
        4
       </month>
       <day>
        14
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       26934220
      </articleid>
      <articleid idtype="pii">
       nature17180
      </articleid>
      <articleid idtype="doi">
       10.1038/nature17180
      </articleid>
      <articleid idtype="pmc">
       PMC5551389
      </articleid>
      <articleid idtype="mid">
       NIHMS756219
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        J Pharm Sci. 2012 Oct;101(10):3979-88
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         22833171
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nature. 2015 May 21;521(7552):362-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25901685
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Mol Pharm. 2009 Jul-Aug;6(4):1145-51
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         19545170
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nature. 2014 Oct 2;514(7520):47-53
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25171469
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):18030-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23071322
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        PLoS Pathog. 2012;8(10):e1002980
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23093940
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        N Engl J Med. 2015 Oct 14;:null
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26465681
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Antiviral Res. 2014 Apr;104:153-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24462697
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Arch Virol Suppl. 2008;20:13-360
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         18637412
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Antimicrob Agents Chemother. 2008 Feb;52(2):458-64
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         17999967
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Antiviral Res. 2014 May;105:17-21
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24583123
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        N Engl J Med. 2015 Dec 17;373(25):2448-54
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26465384
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nature. 2014 Apr 17;508(7496):402-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24590073
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Biochem Biophys Res Commun. 2004 Sep 3;321(4):788-94
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15358096
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Biol Chem. 2010 May 21;285(21):16387-402
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         20351113
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Science. 2015 Feb 13;347(6223):701-2
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25678637
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Antiviral Res. 2016 Jan;125:71-8
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26526586
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Virology. 2005 Feb 5;332(1):20-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15661137
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Viral Immunol. 2015 Feb;28(1):32-41
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25514385
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Cell Rep. 2015 Sep 29;12(12):2111-20
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26365189
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Clin Infect Dis. 2016 Jan 1;62(1):125-6
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26349549
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Virol. 2015 Aug;89(15):7786-98
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25995255
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Nucleic Acids Res. 2004 Sep 08;32(16):4758-67
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         15356293
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        N Engl J Med. 2015 Jun 18;372(25):2423-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25950269
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Antiviral Res. 2014 Jun;106:86-94
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         24713118
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        J Virol. 2013 Mar;87(6):3196-207
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23283954
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Bioorg Med Chem Lett. 2012 Apr 15;22(8):2705-7
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         22446091
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Viruses. 2014 Nov 24;6(11):4666-82
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25421892
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        PLoS One. 2015 Sep 23;10(9):e0139001
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26397100
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        Lancet Infect Dis. 2015 Nov;15(11):1292-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26271406
        </articleid>
       </articleidlist>
      </reference>
      <reference>
       <citation>
        PLoS One. 2012;7(11):e50316
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23209706
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="In-Data-Review">
     <pmid version="1">
      32277065
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       19
      </day>
     </daterevised>
     <article pubmodel="Print">
      <journal>
       <issn issntype="Electronic">
        1083-351X
       </issn>
       <journalissue citedmedium="Internet">
        <volume>
         295
        </volume>
        <issue>
         15
        </issue>
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          10
         </day>
        </pubdate>
       </journalissue>
       <title>
        The Journal of biological chemistry
       </title>
       <isoabbreviation>
        J. Biol. Chem.
       </isoabbreviation>
      </journal>
      <articletitle>
       Halting coronavirus polymerase.
      </articletitle>
      <pagination>
       <medlinepgn>
        4780-4781
       </medlinepgn>
      </pagination>
      <elocationid eidtype="doi" validyn="Y">
       10.1074/jbc.H120.013397
      </elocationid>
      <abstract>
       <abstracttext>
        The nucleotide analogue remdesivir is an investigational drug for the treatment of human coronavirus infection. Remdesivir is a phosphoramidate prodrug and is known to target viral RNA-dependent RNA polymerases. In this issue, Gordon
        <i>
         et al.
        </i>
        identify that remdesivir acts as a delayed RNA chain terminator for MERS-CoV polymerase complexes.
       </abstracttext>
       <copyrightinformation>
        © 2020 Kirchdoerfer.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Kirchdoerfer
        </lastname>
        <forename>
         Robert N
        </forename>
        <initials>
         RN
        </initials>
        <identifier source="ORCID">
         https://orcid.org/0000-0002-5974-2709
        </identifier>
        <affiliationinfo>
         <affiliation>
          Department of Biochemistry, University of Wisconsin-Madison, Madison, Wisconsin 53706 rnkirchdoerf@wisc.edu.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <grantlist completeyn="Y">
       <grant>
        <grantid>
         K99 AI123498
        </grantid>
        <acronym>
         AI
        </acronym>
        <agency>
         NIAID NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
       <grant>
        <grantid>
         R00 AI123498
        </grantid>
        <acronym>
         AI
        </acronym>
        <agency>
         NIAID NIH HHS
        </agency>
        <country>
         United States
        </country>
       </grant>
      </grantlist>
      <publicationtypelist>
       <publicationtype ui="D016428">
        Journal Article
       </publicationtype>
      </publicationtypelist>
     </article>
     <medlinejournalinfo>
      <country>
       United States
      </country>
      <medlineta>
       J Biol Chem
      </medlineta>
      <nlmuniqueid>
       2985121R
      </nlmuniqueid>
      <issnlinking>
       0021-9258
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        12
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        12
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        12
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      ppublish
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32277065
      </articleid>
      <articleid idtype="pii">
       295/15/4780
      </articleid>
      <articleid idtype="doi">
       10.1074/jbc.H120.013397
      </articleid>
      <articleid idtype="pmc">
       PMC7152748
      </articleid>
     </articleidlist>
     <referencelist>
      <reference>
       <citation>
        Sci Transl Med. 2017 Jun 28;9(396):
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28659436
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Sci Rep. 2017 Mar 06;7:43395
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28262699
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nat Commun. 2019 May 28;10(1):2342
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         31138817
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        mBio. 2018 Mar 6;9(2):
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29511076
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        J Biol Chem. 2020 Apr 10;295(15):4773-4779
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         32094225
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Nature. 2016 Mar 17;531(7594):381-5
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         26934220
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        PLoS Pathog. 2013 Aug;9(8):e1003565
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         23966862
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Virus Res. 2017 Apr 15;234:58-73
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         28174054
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):E3900-9
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         25197083
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
     <referencelist>
      <reference>
       <citation>
        Antivir Chem Chemother. 2018 Jan-Dec;26:2040206618764483
       </citation>
       <articleidlist>
        <articleid idtype="pubmed">
         29562753
        </articleid>
       </articleidlist>
      </reference>
     </referencelist>
    </pubmeddata>
   </pubmedarticle>
   <pubmedarticle>
    <medlinecitation owner="NLM" status="Publisher">
     <pmid version="1">
      32281114
     </pmid>
     <daterevised>
      <year>
       2020
      </year>
      <month>
       04
      </month>
      <day>
       13
      </day>
     </daterevised>
     <article pubmodel="Print-Electronic">
      <journal>
       <issn issntype="Electronic">
        1875-9114
       </issn>
       <journalissue citedmedium="Internet">
        <pubdate>
         <year>
          2020
         </year>
         <month>
          Apr
         </month>
         <day>
          13
         </day>
        </pubdate>
       </journalissue>
       <title>
        Pharmacotherapy
       </title>
       <isoabbreviation>
        Pharmacotherapy
       </isoabbreviation>
      </journal>
      <articletitle>
       Delayed Initiation of Remdesivir in a COVID-19 Positive Patient.
      </articletitle>
      <elocationid eidtype="doi" validyn="Y">
       10.1002/phar.2403
      </elocationid>
      <abstract>
       <abstracttext>
        A case of late initiation of remdesivir antiviral therapy in the successful treatment of a patient with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a mixed medical ICU of a community teaching hospital is presented. A previously healthy 40 year-old male was admitted to the hospital three days after the onset of coronavirus disease 2019 (COVID-19) symptoms, including dry cough, fever, and shortness of breath progressing to intubation and increased mechanical ventilator support. A request for compassionate use remdesivir was submitted on the same hospital day as the positive COVID-19 PCR result. Supportive measures, in addition to a 5-day course of hydroxychloroquine, were maintained until remdesivir could be supplied on day 9 of hospitalization, 13 days after symptom onset. Sixty hours after initiating remdesivir, the patient was successfully extubated and was able to transition to room air within 24 hours of extubation. Late initiation of remdesivir may be effective in treating SARS-CoV-2, unlike antivirals utilized for different disease states, such as oseltamivir, which are most effective when started as soon as possible following symptom onset. Urgent action is needed by regulatory agencies to work with drug manufacturers to expedite the study and approval of investigational agents targeting SARS-CoV-2 as well as to meet manufacturing demands.
       </abstracttext>
       <copyrightinformation>
        This article is protected by copyright. All rights reserved.
       </copyrightinformation>
      </abstract>
      <authorlist completeyn="Y">
       <author validyn="Y">
        <lastname>
         Hillaker
        </lastname>
        <forename>
         Emily
        </forename>
        <initials>
         E
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Family Practice Education, Mercy Health Saint Mary's Grand Rapids, Grand Rapids, MI, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Belfer
        </lastname>
        <forename>
         Julie J
        </forename>
        <initials>
         JJ
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Pharmacy Services, Mercy Health Saint Mary's, Grand Rapids, MI, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Bondici
        </lastname>
        <forename>
         Anamaria
        </forename>
        <initials>
         A
        </initials>
        <affiliationinfo>
         <affiliation>
          Division of Infectious Diseases, Mercy Health Saint Mary's, Grand Rapids, MI, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Murad
        </lastname>
        <forename>
         Hani
        </forename>
        <initials>
         H
        </initials>
        <affiliationinfo>
         <affiliation>
          Division of Critical Care, Mercy Health Saint Mary's, Grand Rapids, MI, USA.
         </affiliation>
        </affiliationinfo>
       </author>
       <author validyn="Y">
        <lastname>
         Dumkow
        </lastname>
        <forename>
         Lisa E
        </forename>
        <initials>
         LE
        </initials>
        <affiliationinfo>
         <affiliation>
          Department of Pharmacy Services, Mercy Health Saint Mary's, Grand Rapids, MI, USA.
         </affiliation>
        </affiliationinfo>
       </author>
      </authorlist>
      <language>
       eng
      </language>
      <publicationtypelist>
       <publicationtype ui="D002363">
        Case Reports
       </publicationtype>
      </publicationtypelist>
      <articledate datetype="Electronic">
       <year>
        2020
       </year>
       <month>
        04
       </month>
       <day>
        13
       </day>
      </articledate>
     </article>
     <medlinejournalinfo>
      <country>
       United States
      </country>
      <medlineta>
       Pharmacotherapy
      </medlineta>
      <nlmuniqueid>
       8111305
      </nlmuniqueid>
      <issnlinking>
       0277-0008
      </issnlinking>
     </medlinejournalinfo>
     <citationsubset>
      IM
     </citationsubset>
     <keywordlist owner="NOTNLM">
      <keyword majortopicyn="N">
       COVID-19
      </keyword>
      <keyword majortopicyn="N">
       SARS-CoV-2
      </keyword>
      <keyword majortopicyn="N">
       coronavirus
      </keyword>
      <keyword majortopicyn="N">
       pneumonia
      </keyword>
      <keyword majortopicyn="N">
       remdesivir
      </keyword>
      <keyword majortopicyn="N">
       viral pneumonia
      </keyword>
     </keywordlist>
    </medlinecitation>
    <pubmeddata>
     <history>
      <pubmedpubdate pubstatus="entrez">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        14
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="pubmed">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        14
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
      <pubmedpubdate pubstatus="medline">
       <year>
        2020
       </year>
       <month>
        4
       </month>
       <day>
        14
       </day>
       <hour>
        6
       </hour>
       <minute>
        0
       </minute>
      </pubmedpubdate>
     </history>
     <publicationstatus>
      aheadofprint
     </publicationstatus>
     <articleidlist>
      <articleid idtype="pubmed">
       32281114
      </articleid>
      <articleid idtype="doi">
       10.1002/phar.2403
      </articleid>
     </articleidlist>
    </pubmeddata>
   </pubmedarticle>
  </pubmedarticleset>
 </body>
</html>